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Oligodendrocytes are the myelinating cells of the central nervous system. They are 
derived from oligodendrocyte precursor cells which undergo a complex and precisely 
regulated timed program of proliferation, migration and differentiation finally to form 
the myelin, a multilamellar lipid/protein insulating layer. Myelin wraps around axons 
and enables nerve fibers propagating electric impulses rapidly by saltatory conduction. 
Failure to form a tightly wrapped myelin sheath (dysmyelination), or to maintain it 
(degeneration), results in delayed or disrupted signal transduction, most clearly 
illustrated in the CNS by the autoimmune disease Multiple Sclerosis. 
While the exact mechanisms underlying the specialized wrapping stage of 
myelination have been little elucidated, considerably more is known about how the 
reorganization of actin cytoskeleton and the regulation of actin-binding proteins, 
coupled with those of tubulin cytoskeleton, are mediated by extracellular and 
intracellular signals during oligodendrocyte migration and differentiation. 
 
Juxtanodin was firstly identified as an oligodendroglial protein by screening cell 
type-specific CNS genes. In amino acid sequence, it shared some similarity with ERM 
(ezrin, radixin and moesin) proteins. Previous studies in our lab showed that 
Juxtanodin expression paralleled temporally and spatially the onset of myelination in 
vivo. Furthermore, overexpression of Juxtanodin promoted arborization of cultured 
OLN-93 cells and primary oligodendrocytes. To further clarify molecular interaction, 
Summary 
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possible biochemical effects and mechanisms of activity regulation of Juxtanodin, we 
carried out a series of in vitro and in culture experiments in the current study. 
 
It was found that JN could directly interact with actin and this interaction was 
mediated by the C-terminal F-actin binding domain, which comprised the last 14 
amino acid of JN. Studies on the role of JN in actin dynamics showed that it could 
prevent F-actin depolymerization in vivo and in vitro, suggesting that JN was possibly 
involved in the F-actin based structures and behaviors of oligodendrocyte. As 
expected, JN over-expression in the cultured oligodendrocyte cell line dramatically 
induced the formation of F-actin-based cellular structures, such as filopodia at the cell 
edge and stress-fiber in the cytoplasm. JN also promoted cell spreading and inhibited 
cellular migration.  
 
As expected, the activity of Juxtanodin for actin cytoskeleton should be precisely 
regulated and reversible in vivo, which was supported by the fact that JN partially 
co-localized with F-actin in oligodendrocyte in central nervous system. In the current 
study, the phosphorylation at its serine 278 site was demonstrated to abolish JN’s 
effect on actin dynamics and actin-based structures/behaviors at the biochemical and 
cellular levels. Further study suggested that RhoA GTPase was possibly involved in 
the phosphorylation of serine 278. 
 
Taken together, our results point to Juxtanodin as an actin cytoskeleton-stabilizing 
Summary 
 xx
protein that plays active roles in migration, differentiation of oligodendrocytes and 
maintenance of the myelin sheath. The results also suggest phosphorylation 
modification and RhoA GTPase pathway as important mechanisms in the regulation 












































1.1 Oligodendrocyte and its actin cytoskeleton 
1.1.1 Oligodendrocyte  
Oligodendrocytes (OLs) are the myelinating cells of the central nervous system and 
mainly function to form myelin in vivo. Myelin, the multilamellar lipid/protein 
insulating layer, wraps around axons and enables nerve fibers propagating electric 
impulses rapidly by saltatory conduction (Compston et al., 1997). Failure to form 
functional myelin sheath (dysmyelination) or degeneration of myelin, leads to 
disrupted signal transduction in central nervous system, which is clearly illustrated in 
the autoimmune demyelination disease Multiple Sclerosis (Derfuss et al., 2010; 
Levesque et al., 2010). Oligodendrocytes are derived from oligodendrocyte precursor 
cells (OPCs) (Espinosa de los Monteros et al., 1985; Keilhauer et al., 1985). Along 
the course of maturation, OPCs and oligodendrocytes undergo a complex and 
precisely regulated timed program of proliferation, migration and differentiation 
finally to form the myelin. 
 
1.1.2 Actin cytoskeleton in oligodendrocyte 
1.1.2.1 Cytoskeleton and its roles in oligodendrocyte 
The development of oligodendrocyte relies on the reorganization of their cytoskeleton, 
which consists of microfilaments (MFs) and microtubules (MTs), but not intermediate 
filaments (Wilson and Brophy, 1989; Pfeiffer et al., 1993). For example, mature 
oligodendrocytes in primary cell culture extend numerous lamellipodia and filopodia 
protrusions, which is supported by their cytoskeleton (Kachar et al., 1986). The 
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cytoskeleton also provides the structure basis for the extension and maintenance of 
myelin sheath in vivo (Asou et al., 1994). Moreover, the cytoskeleton plays critical 
roles in the migration of OPCs from the subventricular zone into the different regions 
of the brain and provides the structure basis for intracellular sorting and transportation 
such as transporting the mRNA (messenger RNA) of myelin basic proteins (MBP) 
from the nucleus to the myelin sheath (Brophy et al., 1993; Trapp et al., 1995). 
Especially, recent studies have provided important insights into actin dynamics during 
oligodendrocyte maturation. Microfilaments are found to guide the local 
reorganization of microtubules in the course of oligodendrocyte processes elongation 
and new branches formation in culture (Song et al., 2001; Rumsby et al., 2003). 
Microfilaments are also indicated to play an active role in expression of 2’,3’-cyclic 
nucleotide 3’-phosphohydrolase (CNPase) and MAG (myelin associated glycoprotein) 
during myelination (Fernandez-Valle et al., 1997).  
 
1.1.2.2 Actin-binding proteins in oligodendrocyte 
In oligodendrocytes, a large number of actin-binding proteins have been investigated. 
Arp2/3 (actin related protein 2/3), WASP (Wiskott-Aldrich syndrome protein), 
WAVE (WASP family verprolin-homologous) and vinculin are present in OLs and 
participate in OLs maturation and myelination by spatiotemporally regulating actin 
reorganization (Bacon et al., 2007). For example, mice deficient of WAVE1, which 
could promote actin polymerization through its ability of activating Arp2/3 complex, 
exhibit regional hypomyelination, and oligodendrocyte precursor cell from 
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WAVE1-null mice has fewer processes and defective lamella formation in culture 
(Kim et al., 2006). Nonmuscle myosin IIB has been described to enrich at peripheral 
submembranous regions and the leading edges of processes (Simpson and Armstrong, 
1999), where it interact with MF and may allow the local MF protruding the plasma 
membrane during early stages of differentiation (Song et al., 2001). Mayven is found 
to colocalize with MF in stress fibers (Jiang et al., 2005) and also seems to serve a 
role in oligodendrocyte process outgrowth (Williams et al., 2005). Similar cellular 
distribution and function has been shown for the recently discovered mayven-related 
protein 2 (MRP2) (Jiang et al., 2007). Overexpresston of MRP2 in cultured primary 
oligodendrocytes promotes process elongation, whereas knockdown of MRP2 
expression achieved by antisense RNA obviously results in shorter processes.  
 
Apart from the classical actin-binding proteins as mentioned above, a number of 
myelin-specific proteins are showed to reorganize the actin cytoskeleton in 
oligodendrocytes. CNPase, MBP, proteolipid protein (PLP) and DM20 are present in 
myelin sheath isolated from rat brain, which suggests that these cytoskeleton-related 
proteins may work in coordination and participate in the maintenance of the 
oligodendrocyte cytoskeleton architecture (Arvanitis et al., 2002). MBP binds to actin 
filaments in vitro (Boggs et al., 2006) and could induce its polymerization and the 
formation of F-actin bundling. Notably, this polymerizing activity is 
phosphorylation-dependent. The phosphorylation status of MBP determines its 
location within the cell, with phosphorylated MBP being located primarily to the cell 
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body, whereas dephosphorylated MBP present in the meylin (Boggs et al., 2006). 
Accordingly, at later stages in the myelination process, MBP is predominantly 
dephosphorylated, which enables MBP as an anchoring protein for the actin 
cytoskeleton (Galiano et al., 2006). Although CNPase, which is highly expressed 
during myelination, predominantly binds to MT, it also could interact with MF (Lee et 
al., 2005). It has been described to colocalize with both cortical actin and filopodia 
and may participate in oligodendrocyte process outgrowth.  
 
In addition, myelin also contains some glycoproteins, which are mainly involved in 
the maintenance of myelin and axon-myelin interaction. The examples for the 
myelin-associated glycoproteins include MAG, MOG (myelin/oligodendrocyte 
glycoprotein), and OMgp (oligodendrocyte-myelin glycoprotein) (Pfeiffer et al., 
1993). Recently, it is suggested that these myelin-associated glycoproteins coordinate 
the cytoskeleton of oligodendrocytes to accomplish their functions (Schnaar et al., 
2009).  
 
1.2 Actin cytoskeleton 
1.2.1 Cytoskeletal elements 
A network of intracellular filaments provides structural support and is referred to as 
the cytoskeleton. In addition to its supportive function, the cytoskeleton is also 
involved in numerous important biological processes, such as cell motility, muscle 
contraction, chromosome segregation during cell division, and intracellular transport 
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(Jaeken, 2007). The cytoskeleton comprise of three different components, including 
actin filaments (or microfilaments), intermediate filaments and microtubules, which 
differ in size, the type of subunit they are built up from and the way they are 
assembled.  
 
Microtubules are composed of alpha- and beta-tubulin. Alpha- and beta-tubulin are 
small globular GTPases which can undergo self-association to form hollow 
cylindrical structures that are nucleated at the microtubule organization center 
(MTOC) and the golgi-apparatus in the perinuclear region (Liu et al., 2007; Efimov et 
al., 2007). From these MTOCs, microtubules extend to the cell periphery, 
representing e.g. tracks for motor proteins of the kinesin and dynein families (Mallik 
and Gross, 2004). Microtubules are also indispensable for nuclear division because 
they form the mitotic and meiotic spindles (D'Avino et al., 2005).  
 
Intermediate filaments are generated by a heterogeneous group of proteins categorized 
into five different groups and a conserved substructure shared by intermediate 
filament proteins is necessary for their self-assembly into filaments of approximately 
10 nm in diameter (Eriksson et al., 2009). In contrast to microtubules and actin 
filaments, which are assembled from highly conserved globular proteins with GTPase 
or ATPase activity, the building units of intermediate filaments are not known to have 
enzymatic activity (Chang and Goldman, 2004; Chou et al., 2007). 
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Actin filaments are formed by polymerization of monomeric actin, the highly 
conserved ATPase (Schüler, 2001). Actin is among the most abundant cellular 
proteins and numerous cellular functions have been linked with monomeric actin and 
filamentous actin. The present work is mainly related to actin cytoskeleton. The 




Actin is among the most abundant cellular proteins in the eukaryotic cells. Many key 
cellular behaviors including cytokinesis, endocytosis, motility as well as membrane 
ruffle are dependent on the actin cytoskeleton (Pollard et al., 2001). For multicellular 
organisms, the force required for many morphogenetic processes, such as neuronal 
pathfinding and epithelial folding, was also generated by the actin cytoskeleton 
(Pollard and Borisy, 2003; Pantaloni et al., 2001). 
 
Actin is present in two different forms: one is the monomeric globular actin (G-actin) 
and the other is the assembled filamentous actin (F-actin). Actin monomer consists of 
375 amino acids in the proteins size of approximate 43 kDa (kilodalton). It comprises 
of two domains, which still can be divided into two subdomains numbered from 1 to 4. 
As shown in Fig. 1.1A, between the subdomains 1 and 3 lies a deep hydrophobic cleft, 
which functions as a binding pocket for an adenine nucleotide, ATP or ADP, and a 
divalent metal ion, Mg2+ or Ca2+ (Qualmann and Kessels, 2002). The most favorable 
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state of actin monomers for assembly is Mg2+–ATP–G-actin. On the opposite side of 
actin a small cleft exists, functioning as a binding site for some actin-binding proteins 
(Dominguez, 2004). Actin can undergo conformational changes depending on the 
interaction with nucleotide, cations and actin-binding proteins and its polymerization 
state (Schüler et al., 2001). In the ATP-bound form, the conformation of actin confers 
its high affinity with other actin molecules which induces the self-association into two 
tightly intertwined right-handed helical filamentous polymers of approximate 7 nm in 
diameter (Fig. 1.1B). Single filament comprises of two linear chains of actin 
monomers, which wind around each other into double helix. The pitch of the helix is 
about 37 nm (Sheterline et al., 1995).  
 
Lower organisms, like yeasts, have only one actin protein, whereas higher eukaryotes 
usually have several actin isoforms. In plants, more than 100 different actin genes 
coding for at least 6 actin isoforms were found (McLean et al., 1990). Mammals have 
at least six actin coding genes, which are divided into three groups: α- β- and γ-actins. 
The isoforms are present in cell-type and tissue specific manner. Four isoforms of 
α-actin are predominantly expressed in muscle cells and the less acidic β- and γ-actin 
are mainly found in non-muscle cells (Vandekerckhove et al., 1978; Sheterline et al., 
1995 and Qualmann and Kessels, 2002). Actin isoforms exhibit only small variations 
in amino acid sequence and have similar biochemical properties. The difference of 
actin isoforms in eukaryotes mostly exists in their N-termini, possibly resulting in 




           
 
Figure 1.1 Monomeric actin polymerizes to form filamentous actin. 
A. Ribbon model of an actin monomer B. Schematic drawing of an actin filament C. 
The Electronic Microscope shows an actin filament decorated with myosin at pointed 
end and elongated with ATP-bound actin monomers. (Source: Molecular Biology of 
the Cell, 2004 and Pollard et al., 2002.) 
 
Several proteins with structural homology to actin are present in eukaryotic organisms. 
These proteins form the Arp superfamily (Schafer and Schroer, 1999). Among these 
proteins are Arp2 and Arp3, which are part of a multi-subunit Arp2/3 complex, the 
most potent nucleating factor found so far (Goley and Welch, 2006). Homologues of 
actin are also discovered in prokaryotes. One of them is MreB (murein cluster B), 
which shows little similarity to actin in amino acid sequence but displays functional 
and structural similarity to eukaryote actins. MreB can self-assemble into filaments, 
which are functionally involved in chromosome segregation and cell shape 
maintenance (Graumann, 2007). 
C B A 
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Actin can be post-translationally modified by acetylation (Rubenstein and Martin, 
1983) and arginylation (Karakozova et al., 2006). Recently, it has also been suggested 
that actin is phosphorylated by PKB (protein kinases B) (Vandermoere et al., 2007). 
These modifications alter the biochemical properties of actin probably by influencing 
its association with actin-binding proteins. 
 
1.2.3 Actin dynamics 
Actin filaments extend as the consequence of actin monomers adding to the ends. 
Based on the arrowhead pattern created by the binding of myosin to F-actin (Huxley, 
1963; Wegner, 1976), the rapidly growing end is named the ‘barbed end’, whereas the 
opposite end is called the ‘pointed end’ (Fig. 1.1C). For the actin monomer, 
subdomains 1 and 3 form the barbed end and subdomains 2 and 4 form the pointed 
end (Sheterline et al., 1995; Qualmann and Kessels, 2002). Over thirty years ago it 
was discovered that actin has an intrinsic ATPase activity enabling it to hydrolyze 
bound ATP to ADP and free phosphate (Wegner, 1976). As the filament ages, ATP 
bound to actin monomer is hydrolyzed to ADP and the γ-phosphate dissociates from 
the filament. These events result in conformational changes of the filament which 
favor the dissociation of ADP-actin from the pointed end, resulting in the 
disassembling of actin filament (Fig. 1.2). In vivo, monomeric ADP-actin could not 
bind to F-actin. However, nucleotide exchange to ATP is driven by some 
actin-binding proteins and the generated ATP-actin monomers are ready for a new 
round of polymerization at the barbed end. ‘Treadmilling’ is appointed as the name of 
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this directional F-actin extension, and treadmilling provides the force essential for 
morphogenetic movements, cell motility and many intracellular transport processes 
such as cytokinesis and endocytosis (Pollard and Borisy, 2003; Pantaloni et al., 2001). 
The following sections will focus on the details of actin dynamics. 
 
1.2.3.1 Nucleation 
Nucleation is the first stage for de novo formation of filamentous actin. In vivo, 
polymerization is energetically unfavorable until the nucleus of three associating actin 
monomers is present. In vitro, it is slow to form a nucleus; however, actin-binding 
proteins (ABPs) participate in the process of nucleus formation in vivo and enable the 
nucleation rapidly occurring. Different proteins participate in the formation of new 
actin filaments from the side of existing filaments or de novo, or by severing existing 
filaments. 
 
The Arp2/3 complex is the most well known nucleation protein. It promotes nucleus 
formation from the side of existing filaments (Pollard and Borisy, 2003). As 
mentioned in the section of 1.1.2, Arp2 and Arp3 proteins is structurally similar to 
G-actin, therefore upon binding with G-actin, the Arp2/3 complex is able to generate a 
stable trimer/nucleus for actin filament extension (Goley et al., 2006). Furthermore, 
Arp2/3 complex performs the enhanced activity in vivo by functionally interacting 
with other proteins, most importantly the WASP and WAVE protein. The WASP 
homology 2 (WH2) domain of WASP is able to bind to G-actin, therefore enhancing 
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the nucleating activity of Arp2/3 by feeding actin monomers (Suetsugu et al., 2002). 
In association with cortactin, verprolin/WASP-interacting protein (WIP) proteins also 
could promote Arp2/3-mediated nucleation (Paavilainen et al., 2004). Because Arp2/3 
mainly promotes nucleus formation from the side of existing filaments, it is not 
surprising that Arp2/3 predominantly exists at and is functionally involved in the 
dendritic branching at the leading edge of moving cells (Pollard et al., 2007). 
 
The nucleation stage of actin polymerization could also be driven by the formin 
proteins. Recent studies have indicated that the dimmer of formin homology 2 (FH2) 
domain binds selectively to the barbed end and prevents CapZ homologues from 
capping it, but allows progressive addition of actin monomers on it (Zigmond et al., 
2003; Pollard et al., 2007). In yeast, it is believed that formin proteins initiate the 
nucleation for generating the long actin cables whereas the short branched networks 
required for actin patches are formed by the nucleating action of Arp2/3 (Pollard et al., 
2007). 
 
In vivo, free barbed ends could also be achieved by severing existing filaments. 
Gelsolin and cofilin have been well studied in this field. By severing the pre-existing 
actin filaments, they create free barbed ends ready for the elongation (Ono, 2007). 
The action of their severing actin filaments will be detailed discussed in the following 




1.2.3.2 Actin filament extension, disassembly and stabilization 
Upon nucleated, actin filaments extend rapidly through addition of ATP–G-actin at 
the barded end. The extension of filamentous actin is controlled partly by capping 
proteins. Barbed-end capping proteins, such as CapZ and tensin, selectively bind to 
the barbed end of actin filament and protect it from addition of new monomeric actins, 
therefore inhibiting F-actin extension. In contrast, pointed-end capping proteins 
prevent loss of actin monomers from the pointed end, so acting to promote filament 
extension (Cooper et al., 2008). 
 
As the filaments age, ATP bound with actin monomer is hydrolyzed by the intrinsic 
ATPase activity of actin and the ADP-actin favors to dissociation from the pointed 
end of actin filaments, resulting in their disassembling. The actin-depolymerizing 
factor (ADF) and the members of cofilin family play a critical role in actin filaments 
disassembling. These ubiquitous and highly conserved proteins bind to ADP–F-actin 
and drive the dissociation of ADP-actin from filaments (Van Troys et al., 2008). The 
depolymerization activity of cofilin can further be enhanced by interaction with AIP-1 
(actin-interacting protein 1) (Okada et al., 1999).  
 
Tropomyosins are also important ABPs in actin dynamics. The members of this highly 
conserved tropomyosins family bind along the actin filaments and stabilize the 
filaments against spontaneous depolymerization (Gunning et al., 2008). Furthermore, 
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tropomyosins are capable of antagonizing gelsolin- and ADF/cofilin-mediated 
depolymerization by competitive binding to actin filaments (Kuhn et al., 2008). 
 
1.2.4 Actin-binding proteins 
As mentioned in the above sections, actin dynamics in cells is precisely regulated by 
many actin-binding proteins, whose activities are under the spatiotemporal control of 
different signaling pathways. Many actin-binding proteins are ubiquitously expressed 
and highly conserved between different organisms, therefore, probably playing 
fundamental roles in regulating common biological processes, whereas some 
actin-binding proteins exist only in certain cells, thus, probably participating in 
specific cellular behaviors. In view of their binding characterization and functional 





Figure 1.2 Actin dynamic model.  
WASp/Scar proteins are initiated by the active forms of Rho-family GTPases and 
PIP2, which are produced by the association of extracellular stimulus with the 
membrane receptors. WASp/Scar proteins functionally bind with Arp2/3 complex and 
promote its nucleation activity to initiate growth of new actin filament on the side of a 
pre-existing actin filament. Progressive addition of actin monomers at the barbed end 
of the new branched filament induces its rapid extension and pushes the membrane 
forward. Within a second or two, the capping proteins bind to the barbed end and 
prevent the addition of actin monomers on it, terminating the F-actin extension. 
Filaments age through hydrolysis of ATP bound to actin subunit (white subunits turn 
yellow) and dissociation of the  phosphate (subunits turn red). ADF/cofilin 
promotes phosphate dissociation, severs ADP-actin filaments and promotes 
dissociation of ADP-actin from filament ends whereas profilin catalyzes the 
nucleotide exchange of ADP to ATP (turning the subunits white), ensuring the 
maintenance of the pool of ATP-actin monomers which are ready to new rounds of 
F-actin extension. (Redrawn from a figure in Pollard et al., 2000).  
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1.2.4.1 Actin monomer binding proteins  
The elongation of actin filaments requires the availability of ATP bound actin 
monomers at a high concentration in cells. The critical concentration (approximate 0.1 
μM) for the polymerization of ATP-actin monomers into filaments is distinctly 
exceeded in most cells, which suggests that spontaneous nucleation or polymerization 
of actin filaments could be inhibited by some actin-binding proteins (Paavilainen et 
al., 2004). In cells, a large pool of actin monomers is maintained by actin monomer 
binding proteins. Actin monomer binding proteins also regulate the nucleotide status 
(ADP bound or ATP bound) of actin monomers (Paavilainen et al., 2004). Moreover, 
some actin monomer binding proteins govern the subcellular localization of actin 
monomers, which means that actin dependent cellular processes at desired cell regions 
could be achieved by these proteins (Sun et al., 1995). Therefore, actin monomer 
binding proteins play critical roles in actin dynamics in vivo. Although a large 
numbers of actin monomer binding proteins have been reported (more than 25 in 
mammals), only six distinct families classified by their different evolution and 
function are ubiquitously expressed: ADF/cofilin, profilin, twinfilin, 
Srv2/cyclase-associated protein (CAP), WASP/WAVE and verprolin/WIP proteins. In 
cells, profilin, Srv2/CAP, ADF/cofilin and twinfilin are abundant in molar ratios with 
actin of maximally 1:10 (Pollard et al., 2000), which is consistent of their function of 
maintaining a large pool of actin monomers. WASPs and Verprolin/WIP, by contrast, 
participate in signaling pathway as activating the Arp2/3 complex under certain 
stimulus; therefore they are much less in cells (Stradal et al., 2006). 
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A brief process for the roles of actin monomer binding proteins in the regulation of 
actin dynamics is elucidated as follows. As shown in Fig. 1.2, ADF/cofilin binds to 
aged actin filaments and drives the dissociation of ADP–G-actin from the pointed end. 
Srv2/CAP is capable of recycling ADP–G-actin and ADF/cofilin for new rounds of 
filament polymerization and depolymerization, respectively. Moreover, CAP proteins 
in mammal have the activity of catalyzing nucleotide exchange from ADP to ATP on 
G-actin (Balcer et al., 2003). After releasing from Srv2/CAP proteins, ATP–G-actin 
was added at barbed end with the assistance of profilin (Witke et al., 2004). For the 
actin monomers that diffuse away from the regions of rapid actin assembly, twinfilin 
could sequester and recruit them to the desired regions (Palmgren et al., 2002). 
During the process of transport, twinfilin forms a stable complex with G-actin and 
inhibits their nucleotide exchange, therefore preventing their assembly. After reaching 
the desired region of rapid filament elongation, actin monomers dissociate from 
twinfilin complex by the competitive binding of the capping proteins. Furthermore, 
they implement the nucleotide exchange with the assistance of profilin and add to the 
barbed end (Palmgren et al., 2001). 
 
1.2.4.2 Actin filament capping proteins  
Although some proteins, such as Arp2/3, show the ability of capping pointed end of 
actin filament, barbed-end capping proteins, like CapZ, are prominent capping 
proteins in cells (Kueh et al., 2008; Cooper and Sept, 2008). The name of ‘CapZ’, 
capping protein in striated muscle, is inspired for its location at F-actin barbed end at 
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the Z line (Caldwell et al., 1989). Expression of a mutant CapZ incapable of binding 
actin results in severe disruption of heart sarcomere in mice (Hart and Cooper, 1999). 
When actin polymerization is initiated, free barbed ends are created by the ways 
mentioned in the above section of ‘1.1.3.1 Nucleation’ and processively added with 
actin monomers. Over time, the barbed ends are bound with capping proteins (Fig. 
1.2), leading to the termination of actin filament growth. The cessation of filament 
extension by the activity of capping proteins is precise regulated and is necessary for 
the desired polymerization at certain place in vivo. Because almost all the barbed ends 
are blocked by capping proteins, actin monomers will be confined or ‘funneled’ to the 
free barbed ends for localized actin assembly (Carlier and Pantaloni, 1997). This 
hypothesis has been experimentally supported by the fact that capping protein is 
indispensable for actin polymerization in a system comprising pure proteins from 
Listeria (Loisel et al., 1999). In consistence with the biochemical study, capping 
protein is expressed in the moving tails of Listeria and Listeria loses its ability of 
motility when its capping protein is exhausted in vivo (David et al., 1998). The model 
is also supported by the observation that loss of capping protein in Dictyostelium 
decreases its motility (Hug et al., 1995). 
 
Capping proteins can be removed from the barbed end by polyphosphoinositides in 
vitro and in vivo (Schafer et al., 1996). Also, some proteins such as formin can protect 




1.2.4.3 Actin filament severing proteins  
Gelsolin and ADF/cofilin are two well studied proteins in this field. Gelsolin severs 
actin filaments in the presence of Ca2+ (Kwiatkowski et al., 1999).  Because it caps 
the barbed end of actin filament whereat it severs, gelsolin must be removed with the 
assistance of phosphoinositides for the availability of the free barbed end (Hartwig et 
al., 1995). As shown in Fig. 1.2, in addition to their function of dissociating actin 
monomers from the filament pointed end, the ADF/cofilin proteins also can sever 
filaments to generate free barbed ends (Chan et al., 2000). As ADF/cofilin could not 
stay at the barbed ends of the filaments they severed, free barbed ends are directly 
generated for actin filaments extension (Andrianantoandro and Pollard et al., 2006; 
Michelot et al., 2007). Because ADF/cofilin can simultaneously promote actin 
polymerization and depolymerization, ADF/cofilin is regarded as a vital player in 
generating transients of actin polymerization/depolymerization in vivo (Oser et al., 
2009). 
 
1.2.4.4 Actin filament bundling/crosslinking proteins 
The morphology and function of cells are crucially dependent on the organization of 
actin filaments into higher-order structures. These solid actin structures generally 
provide the mechanic basis for the morphology and order in cells such as the ordered 
architecture of striated muscle and the microvilli of brush border epithelial cells (Rice 
et al., 1970; Bretscher and Weber et al., 1978). Some cellular functions, however, 
closely relate to the transient actin structures, for example, filopodia at the leading 
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edge of moving cells (Sepsenwol et al., 1989; Westphal et al., 1997). Whereas the 
dendritic branches of F-actin are initiated by Arp2/3-induced 
nucleation/polymerization, other F-actin structures are generated by the F-actin 
bundling or crosslinking activities (Chan et al., 2009; Goley et al., 2010). F-actin 
bundling proteins align actin filaments parallel or antiparallel to form linear bundles 
(Johnson and Schell et al., 2009; Shin et al., 2009; Higaki et al., 2010). As expected, 
F-actin bundling proteins contain two F-actin binding domains in their sequences or 
could form multimeric proteins if only one F-actin binding domain is present in their 
sequences (Winder et al., 2003). Actin bundles are further classified into loose or tight 
forms. Tight F-actin bundles as found in microvilli are generated by the close 
presence of two F-actin binding domains (Drenckhahn et al., 1988). However, 
α-actinin forms the more loosely ordered actin structure of stress fibers. α-actinin has 
a single actin-binding domain in its sequence and they exhibit bundling activity by 
forming the dimeric protein. The two actin-binding domains of the dimeric α-actinin 
are separated by a helical spacer region, which results in some distance apart between 
the domains and therefore a looser association of actin filaments (Sjöblom et al., 
2008). The orthogonal arrays of actin filaments are achieved by F-actin crosslinking 
proteins or multimeric proteins containing multiple actin-binding domains (Klein et 
al., 2004; Hampton et al., 2008). Generally, longer and more flexible spacer regions 
between the actin-binding domains such as filamin lead to a more perpendicular 
arrangement of actin filaments (Schmoller et al., 2009). However, under certain 
conditions, organization of actin filaments into dense meshwork could also be 
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achieved by small monomeric proteins mediated crosslinking activity, such as 
transgelin (Assinder et al., 2009). 
 
In addition to binding F-actin, a numerous and diverse range of ABPs can interact 
with other proteins, thereby acting within signaling networks of cells to allow 
remodeling of the cellular actin cytoskeleton. For example, cortactin, a SH3-domain 
containing protein, plays a critical role in membrane trafficking and cell adhesion 
(Lua et al., 2005); VASP and vinculin which contain poly-proline motifs are capable 
of recruiting components of the actin polymerization machinery to reorganize actin 
cytoskeleton of cells (Quinlan, 2004). 
 
1.2.5 Actin filaments based cellular structures  
Ectopical expression of our target protein (Juxtanodin) in cells generates lamellipodia-, 
filipodia- and stress fiber-like cellular structures. The three actin filaments based 
structures are discussed in the following sections. 
 
1.2.5.1 Lamellipodia  
The lamellipodia are defined as surface-attached sheet-like membrane protrusions 
observed during cell motility and spreading. Abercrombie et al. first defined the key 
characteristics of the lamellipodia. The lamellipodia extend several micrometres back 
from the leading edge of moving cells (Abercrombie et al., 1970). And, lamellipodia 
are thin (100 to 160 nm), less adherent, devoid of organelles and dynamic 
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(Abercrombie et al., 1971). It is thought that the dendritically branched actin 
filaments in lamellipodia are initiated by the Arp2/3-complex (Lai et al., 2008).  
 
1.2.5.2 Filopodia  
Filopodia are defined as finger-like protrusions that are adhered to the substratum and 
they protrude mostly from the leading edge of many motile cells such as nerve growth 
cones (Faix and Rottner, 2006). Filopodia are thought to function as directional sensor 
(Zheng et al., 1996), possibly by enrichment of activated integrins in filopodial tips 
(Galbraith et al., 2007). Filopodia are also abundant on neuronal dendrites and seem 
to play an important role in dendritic spine development (Jontes and Smith, 2000). 
 
As shown in Fig. 1.3, filopodia are abundant of tight F-actin bundles (Small, 1982). 
The mechanism and site for filopodia assembly are currently controversial. The most 
popular model is described as filopodia assemble by 'convergent elongation' of 
lamellipodial filaments (Vignjevic et al., 2006). Briefly, filopodia which extend deep 
into the lamellipodia are formed by reorganization of the Arp2/3-mediated dendritic 
network into bundles. This arrangement is achieved when the barbed ends of actin 
filaments at the leading edge associate with proteins as VASP and formins, which 
protect the barbed ends from capping and allow the elongation of actin filaments. 
Finally, the bundling proteins such as fascin would bundle the contacting actin 





Figure 1.3 Structure of a filopodium. 
Filopodia are a finger-like, actin-rich protrusions. Mostly, filopodia extend deep into 
the lamellipodia and the convergent-elongation model of filopodial assembly is 
described as filopodia a formed by reorganization of the Arp2/3-mediated dendritic 
network into bundles. This model is supported by the discovery that Ena/Vasp, 
formins and myosin X are enriched at the tips of filopodia and fascin, a bundling 
protein, is present in most filopodium. (Source: The Manual of Cellular and 
Molecular Function, 2008) 
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1.2.5.3 Stress fibers 
Stress fibers are contractile bundles of around 10 to 30 anti-parallel actin filaments 
(Deguchi et al., 2009). Some bundling proteins such as α-actinin, filamin, espin and 
fascin have been detected in stress fibers (Pellegrin and Mellor, 2007). Myosin II is 
also present in the stress fibers (Lazarides and Burridge, 1975) although binding of 
myosin II to stress fibers is mutually exclusive with the binding of α-actinin 
(Hotulainen and Lappalainen, 2006). In contrast to the sarcomeric structure of muscle 
cells, where each block of bundled actin filaments shows opposite polarity to its 
successive blocks, stress fibers of nonmuscle cells probably show a variety of other 
orientations (Deguchi et al., 2009). Stress fibers observed in fibroblasts have been 
divided in three different categories: dorsal stress fibers, transverse arcs and ventral 
stress fibers (Heath and Holifield, 1993). These structures interact directly with one 
another to form a continuous and dynamic network (Hotulainen and Lappalainen, 
2006). 
 
Focal adhesions have emerged as points of dorsal stress fiber formation. In a recent 
elegant live-cell imaging analysis (Hotulainen and Lappalainen, 2006), the evidence is 
provided that dorsal stress fibers arise from focal adhesions through the nucleation of 
actin filaments by DRF (diaphanous-related formin) mDia1, a member of the formin 
family. Stress fibers originate at the focal adhesions with a growth rate of around 
0,2-0,4 μm/min (Endlich et al., 2007; Hotulainen and Lappalainen, 2006). Dorsal 
stress fibers can interact with transverse arcs or other focal adhesions. Myosin II could 
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not be detected in elongating dorsal stress fibers, but seems to be incorporated at later 
time points (Hotulainen and Lappalainen, 2006). Transverse arcs form by the 
assembly of small F-actin bundles of opposing orientation that are generated at the 
leading edge. These short F-actin bundles are bundled by α-actinin and form longer 
bundles by annealing in an end-to-end manner with myosin II filaments (Hotulainen 
and Lappalainen, 2006). After their generation, arcs flow towards the cell center and 
form contractile arrays. Ventral stress fibers are reported to form through the 
interaction of growing dorsal stress fibers with arcs and a subsequent joining of the 
two dorsal stress fibers which results in a graded polarity of actin filaments and the 
ability to contract (Hotulainen and Lappalainen, 2006). Since both ends of the 
resulting ventral stress fiber originate from a focal adhesion, ventral stress fibers are 
spanned between these adhesions and able to exert force between these two anchoring 
points.  
 
The contraction of stress fibers advances the cell body during cell migration. Stress 
fiber assembly and contraction is regulated through the Rho-GTPase pathway 
(Albiges-Rizo et al., 2009). Contraction is the result of myosin II interaction with 
actin. Myosin II is a hexamer composed of two myosin heavy chains and two pairs of 
essential and regulatory myosin light chains (MLC) (Bagshaw, 2000). Myosin II 
forms bipolar filaments that interact with F-actin and convert chemical energy derived 




1.3 ERM proteins and Juxtanodin 
Ezrin, radixin and moesin (ERM proteins) have been found to express in many kinds 
of cells and play critical roles in connection of the actin cytoskeleton to various 
membrane proteins. Juxtanodin, a recently indentified oligodendrogila protein, is 
regarded as a distant member of this family in view that it structurally relates to the 
ERM proteins (Zhang et al., 2005; Brockschnieder et al., 2006). The following 
sections would focus on the current understanding on Juxtanodin protein. The ERM 
proteins would also be detailed discussed, from expression profiles to functional 
relationship with biological processes, which provides important clues to the study on 
Juxtanodin. 
 
1.3.1 ERM proteins 
1.3.1.1 Structure of ERM proteins 
The ERM family comprise of three evolutionally and functionally related proteins: 
ezrin, radixin and moesin. Ezrin (approximately 82 kDa) was originally identified as a 
component of microvilli on the apical side of polarized epithelial cells (Bretcher, 
1983). Radixin (approximately 80 kDa) was isolated from adherent junctions of rat 
liver (Tsukita et al., 1989), but seems to be primarily enriched at the microvilli of bile 
canaliculi (Crepaldi et al., 1997). Moesin (approximately 75 kDa) was identified from 
bovine uterus as a heparin-binding protein (Lankes et al., 1988). Homologues for 






Figure 1.4 Structure of ERM proteins. 
Each of ERM proteins has three domains: a globular N-terminal membrane-binding 
domain, followed by an extended -helical domain and a C-terminal actin-binding 
domain. The identity of amino acid sequence with ezrin in each domain is indicated. 
 
As shown in Fig. 1.4, the amino acid sequences of ERM N-terminal 
membrane-binding domain are highly conserved (approximately 85% identity) and 
are similar to the N-terminal half of human erythroid band 4.1 protein, suggesting that 
the ERM proteins are members of the band 4.1 superfamily (Diakowski et al., 2006). 
The N-terminal domain of band 4.1 superfamily, refer to FERM (4.1 and ERM) 
domain, consists of around 300 amino acids and is a module responsible for the 
plasma membrane localization (Pearson et al., 2000). As shown in Fig. 1.4, in ERM 
proteins, the FERM domain is followed by an extended α-helical domain and a 
C-terminal actin-binding domain (Fehon et al., 2010). Based on their structure, ERM 
proteins have been suggested to function as the crosslinkers between the plasma 




1.3.1.2 Distribution and functions of ERM proteins 
Immunoblotting analysis and immunofluorescence microscopy studies reveal that the 
expression pattern of ERM proteins appears to be regulated in a cell type-specific 
manner. ERM proteins have been shown to concentrate at the cell-surface structures 
such as filopodium, microvillus, ruffling membranes and cell adhesion sites in 
cultured cells, where actin cytoskeleton are closely connected with plasma 
membranes (McClatchey and Fehon, 2009). Knockdown of all ERM proteins by 
antisense oligonucleotides in cultured fibroblasts or epithelial cells disrupts 
microvillus formation as well as cell-to-cell/cell-to-substrate adhesion (Takeuchi et al., 
1998). Similarly, in cultured neurons that mainly contain radixin and moesin, 
inhibition of their expression severely affects the morphology, motility, process 
formation of growth cones and dendritic filopodia formation (Paglini et al., 1998; 
Furutani et al., 2007; Parisiadou et al., 2009). Selective ablation of ezrin by 
MicroCALI (chromatophore-assisted laser irradiation) in cultured neurons inhibits the 
membrane ruffling and motility (Lamb et al., 1997). Furthermore, overexpression of 
full-length ERM proteins appears to enhance cell adhesion (Henry et al., 1995). These 
reports suggest that ERM proteins crosslink plasma membranes and actin 
cytoskeleton respectively by their N- and C-terminal domain to function in the 
cortical actin organization. Recent studies also highlight the importance of ERM 
proteins in controlling the distribution of membrane receptors, thereby contributing to 




In the human brain, predominant expression of moesin in endothelial cells, microglia 
and neurons is detected by immunofluorescence (Grönholm et al., 2005). A recent 
investigation shows that radixin is strongly expressed in neuroblasts of the 
subventricular zone, and also in Olig2-positive cells (Persson et al., 2010). An 
ultrastructural analysis by electronic microscope also reveals that ezrin and radixin are 
concentrated in perisynaptic astroglial processes, which also contain other 
characteristic actin-associated molecules and constitute the perisynaptic glial sheath 
(Derouiche and Frotscher, 2001). In the peripheral nervous system (PNS), ERM 
proteins are concentrated in the perinodal schwann cell microvilli and are strongly 
implicated in promoting Ranvier node formation and axon-associated schwann cell 
motility (Gatto et al., 2003; Gatto et al., 2007). In the central nervous system, the 
similar Ranvier node is present but the perinodal oligodendrocytes are absent of ERM 
proteins expression (Scherer et al., 2002).  
 
1.3.1.3 Actin and membrane binding of ERM proteins 
The actin-binding domain of ERM proteins is identified as the last C-terminal 
34 amino acids, which is highly conserved among these proteins (Turunen et al., 
1994). In addition to this domain, two more actin-binding domains capable of binding 
F-actin and G-actin have been identified in N-terminal and middle regions of ezrin 
(Roy et al., 1997), suggesting the model for association of actin with ERM proteins 
does not appear to be simple. Meanwhile, ERM N-terminal domains is found to 
directly interact with the cytoplasmic domains of CD44 (Hirao et al., 1996), ICAM-1 
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(inter-cellular adhesion molecule 1) and CD43, which are co-localized with ERM in 
vivo (Heiska et al., 1998). This direct binding of ERM with integral membrane 
proteins is indicated to be essential for cell-surface morphogenesis such as microvillus 
formation (Yonemura et al., 1999).  
 
1.3.1.4 Conformational regulation of ERM proteins  
Given that the cortical actin filaments are dynamically organized in response to 
various signals, ERM proteins activity of cross-linking actin cytoskeleton with plasma 
membrane is expected to be dynamically regulated. Amount of evidence has 
demonstrated that there are active and inactive forms of ERM proteins in cells. In 
vitro and in vivo, the ERM N- and C-terminal domains interact intramolecularly and 
mutually inhibit the actin filament and membrane binding activities (Gary and 
Bretscher, 1995). The region involved in the intramolecular interaction is narrowed 
down to residues 1-297 and 480-586 as exemplified in ezrin, and these regions are 
called N- and C-ERMADs (ERM-association domains), respectively (Gary and 
Bretscher, 1995). Moreover, these N- and C-ERMADs are also responsible for 
oligomerization of ERM proteins, i.e. intermolecular interaction of ERM proteins 
(Mangeat et al., 1999), which is supported by the presence of the ERM oligomers in 
cells (Gautreau et al., 2000). It is now accepted that the mechanism of intramolecular 
mutual suppression keeps ERM proteins in an inactive state and that some activation 




The activation of ERM is accomplished through the disruption of their intramolecular 
or intermolecular interaction. After that, they translocate from the cytoplasm to the 
cytoskeleton beneath the plasma membrane to function as cross-linkers between 
plasma membrane and actin cytoskeleton (Gary and Bretscher, 1995). So far, two 
ways have been shown to activate ERM proteins: phosphorylation of threonine 
residue at the C-terminal domain (T557 in mouse moesin) and PIP2 binding to the 
N-terminal domains, which weaken the intramolecular self-association and allow the 
N- and C-ERMADs to interact with other proteins. In Drosophila, the phosphorylation 
of moesin at the C-terminal threonine residue induced by the sterile 20 family kinase 
Slik activates moesin and generates epithelial filopodia formation (Hughes et al., 
2010). This site of threonine residue is also effectively phosphorylated by PKC-θ 
(protein kinase C) (Pietromonaco et al., 1998; Kim et al., 2010), spleen tyrosine 
kinase (Coffey et al., 2009), lymphocyte-oriented kinase (Belkina et al., 2009) and G 
protein-coupled receptor kinase 2 (Kahsai et al., 2010) and so on. Furthermore, 
immunofluorescence study with the antibodies specific for C-terminal 
threonine-phosphorylated ERM proteins reveals that ERM proteins localized beneath 
plasma membranes are actually phosphorylated at the C-terminal threonine in vivo 
(Hayashi et al., 1999). Taken all together, it seems that the threonine phosphorylation 
maintains the activated ERM proteins. However, phosphorylation of tyrosine and 
threonine at ERM N-terminal domains has also been reported, suggesting that 
regulation of ERM by phosphorylation is more complex than we thought (Yang and 
Hinds, 2003). Another activator for ERM proteins is phosphatidylinositol 
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4,5-bisphosphate (PIP2), which directly binds to the ERM N-terminal halves in vitro 
and facilitates ERM activation in vivo (Yonemura et al., 2002). 
 
Because native ERM proteins have a tendency to inactivate themselves by the 
intramolecular interaction, the down-regulation of activation signals may inactivate 
ERM proteins in cells. For example, concomitant with microvillar breakdown, ERM 
proteins are dephosphorylated at the C-terminal threonine, resulting in their 
inactivation and cytoplasmic translocation (Kondo et al., 1997). Myosin light chain 
phosphatase has been shown to bind moesin in vitro, possibly acting as an in activator 
for moesin by dephosphorylation of the C-terminal threonine (Fukata et al., 1998). On 
the other hand, proteolysis could be another way of inactivation of ERM proteins 
because ezrin is a substrate for calpain in vitro (Wang et al., 2005). So far, it is 
accepted that the balance of activation and inactivation signals regulates the ERM 
functions. 
 
1.3.1.5 Crosstalk between ERM proteins and Rho GTPases 
GTPases are molecular switches controlling complex cellular signaling pathways. It is 
easily achieved by cycling their two conformational states: GTP-bound state (active 
form), GDP-bound state (inactive form). In their active state, GTPases participate in 
the signaling pathways by binding to the target proteins until GTP hydrolysis by their 
intrinsic GTPase activity returns them to the inactive state. Several hundred GTPases 
have been found in mammalian cells (Boureux et al., 2007). The Ras superfamily of 
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GTPases, which comprised Ras, Rho, Rab, Arf and Ran families, is particularly 
important because the members have been reported as the master regulators for many 
cell behaviors, such as exocytosis, muscle cell contraction, membrane trafficking, 
cellular morphology and ribosome assembly and so on (Britton, 2009; Stenmark, 
2009; Lee et al., 2009; Pucadyil and Schmid, 2009; Gad and Aspenström, 2009; Kahn, 
2009; Vitale, 2010).  
 
Rho GTPases family is primarily found to regulate actin dynamics in cells and further 
studies explore their important roles in many common cellular behaviors such as 
microtubule dynamics, gene transcription, apoptosis, cell polarity and cell 
proliferation (Rooney et al., 2010; Hall and Lalli, 2010; Takesono et al., 2007; Kim et 
al., 2010; Lin et al., 2009; Peters et al., 2009; Kobayashi et al., 2010; Bosco et al., 
2010). As shown in Fig. 1.5, the regulation of Rho is very elaborate. So far, more than 
sixty guanine nucleotide exchange factors (GEFs) acting as the activators and seventy 
GTPase-activating proteins (GAPs) acting as the inactivators for Rho GTPases have 
been found in human genomics (Boureux et al., 2007). Rho, Rac and Cdc42 are three 
well-studied members in this family. Over-expression of constitutively activated 
mutants of Rho and Rac in a wide eukaryotic cell types is shown to promote the 
formation of stress fiber and lamellipodia, respectively, whereas Cdc42 induces the 





Figure 1.5 The Rho GTPases cycle. 
More than twenty Rho GTPases have been reported in mammalian, including Rho 
(isoforms of A, B, C), Rac (1, 2, 3) and Cdc42. They cycle between a GTP-bound 
(active) and a GDP-bound (inactive) conformation. Over 60 target proteins have been 
reported as the effectors of their active forms. The cycle is precisely regulated by 
GEFs, which drive the nucleotide exchange and activation of Rho GTPases, GAPs, 
which promote GTP hydrolysis and lead to the inactivation of Rho GTPases, and 
GDP dissociation inhibitors (GDIs), which maintain the inactive form of Rho 
GTPases. (Source: Sandrine and Alan, 2002) 
 
The question has arisen with regard to the relationship between Rho GTPases and 
ERM proteins. So far, in vitro and in vivo studies have indicated close association 
between RhoA GTPase and ERM proteins. The binding ability of ERM to CD44 in 
crude cell homogenate is enhanced by activation of RhoA (Hirao et al., 1996). 
Furthermore, transfection of the constitutively active mutant of RhoA, but not that of 
Rac or Cdc42, induces microvillus formation to which ERM proteins are recruited 
(Matsui et al., 1999; Shaw et al., 1998), suggesting that ERM proteins are 
downstream factors for RhoA GTPase in vivo. However, it still remains unknown 
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whether ROCK (Rho-associated protein kinase), which is a downstream effector of 
RhoA GTPase and effectively phosphorylates the C-terminal threonine of ezrin in 
vitro, could directly bind to and activate ERM in vivo.  
 
Phosphatidylinositol 4-phosphate 5-kinase (PI4P5K), which increases the amount of 
PIP2, is a direct substrate of RhoA (Ren and Schwartz, 1998). Because activation of 
ERM proteins is induced by PIP2 in vivo as well as in vitro (Hirao et al., 1996; Matsui 
et al., 1999), one possible pathway for the activation of ERM proteins is described as 
follows. RhoA may activate PI4P5K, which in turn produces PIP2. PIP2 then 
activates ERM proteins by inhibiting their intramolecular interaction, which allows 
the phosphorylation of their C-terminal threonine residue. The 
threonine-phosphorylated ERM proteins are stabilized as activated forms, which 
function as cross-linkers between the plasma membrane and the actin cytoskeleton. 
Moreover, the presence of Rho-GDI has been identified in the precipitated proteins 
with ERM (Hirao et al., 1996). In vitro binding assays reveal that active ERM 
proteins can directly bind with Rho-GDI at their N-terminal halves and suppress GDI 
activity, leading to the activation of RhoA (Takahashi et al., 1997). These findings 
suggest that ERM proteins, once activated, can activate RhoA, which again activates 
ERM proteins as a positive feedback system. Therefore, ERM proteins are pointed as 






1.3.2.1 Molecular character and expression of Juxtanodin 
Juxtanodin (JN) consists of 282 amino acid residues with high contents of glutamic 
acids and serines. In comparison with characterized proteins, JN exhibits an ERM-like 
C-terminal actin-binding domain and a similar extended α-helical domain although it 
lacked the N-terminal membrane-binding FERM domain found in all known ERM 
proteins. Hence, it might belong to the ERM protein family (Zhang et al., 2005; 
Brockschnieder et al., 2006). 
 
By using ISH, JN mRNA is detected in the perikarya of glia-like cells throughout the 
CNS (central nervous system). As shown in Fig. 1.6, double-labeling results show that 
at the cellular level, JN in the rat CNS is specifically localized in oligodendrocytes 
given its colocalization with CNPase, a cytoskeleton-related oligodendroglial protein, 
but not with astrocyte (GFAP), neuron (neurofilament 200) or microglia (OX42) 
markers. Subcellularly, JN distribution overlaps that of CNPase substantially but not 
completely. On cross section of fiber tracts of cervical spinal white matter, for 
example, CNPase often labels the abaxonal and adaxonal layers of the myelin sheath. 
JN coexists with CNPase mostly in the abaxonal (outer) ring and, at times, a small 
part of the adaxonal (inner) ring. Of CNS myelinated axons, the conventional terminal 
(paranodal) loops of myelin sheath are not homogeneous in their molecular 
composition (Kazarinova-Noyes and Shrager, 2002; Susuki and Rasband, 2008). As 
revealed by confocal microcopy and immunoelectron microscopy study, JN 
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distribution in the node-abutting lateral terminal loops of myelin sheath 
morphologically defines a juxtanode region between the paranode and the node of 
Ranvier. Western blot analysis demonstrates JN emergence during CNS ontogenesis 
parallels that of major MBP isoforms and coincides with the onset of myelination. 
However, JN is not detected in the Schwann cells of spinal dorsal roots, suggesting its 
absence in the PNS. The isoform of JN may exist in the central nervous system, which 
is supported by the northern blot analysis and blast search of EST cDNA 
(complementary DNA) database. 
 
Figure 1.6 Expression of JN in central nervous system. 
Double immunofluorescence of JN with CNPase (B and C), GFAP (D), neurofilament 
200 (E), or OX42 (F) in layers III and IV of frontal cortex from adult rats. In all 
panels, single-labeling would appear red (JN) or green (others). Yellow indicates 
double-labeling. Open arrowheads denote cell bodies of oligodendrocytes. Scale bars: 
10 μm. (Source: Zhang et al., 2005) 
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1.3.2.2 JN in myelination and specialization of the node of Ranvier 
The maturation of oligodendrocytes is characterized by process outgrowth and 
refinement, the programmed appearance and redistribution of certain marker 
molecules, such as CNPase and MBPs, and the formation of myelin sheath (Sher et al., 
2005). Expression of JN in the developing forebrain lags behind that of CNPase, 
parallels those of major MBP isoforms, and coincides with the onset of myelination 
therein. This order of expression-onset of CNPase, MBPs, and JN in vivo seems to be 
preserved in cultured primary OLPs, in which JN does not appear before at least 10 
days in culture. The immunohistochemical studies in the developing CNS also 
confirm this observation. These findings suggest that JN plays critical roles in the 
maturation of oligodendrocytes and the myelin formation. Moreover, the JN-positive 
juxtanode region neighboring node of Ranvier clearly differs from those JN-negative 
medial terminal loops adjoining the juxtaparanode. Accompanying this molecular 
heterogeneity, functional disparity between the two regions is expected. Hence, the 
proposed distinction of juxtanode from the paranode may bear important functional 
implications. The former might, for example, be more related to myelin-axon 
interaction or to induction/sustaining of the node of Ranvier, whereas the latter may 
be more involved in the formation/maintenance of compact myelin lamellae.  
 
Taken together, the previous findings indicate important roles of JN in late-stage 
oligodendroglia maturation, in myelin/Ranvier node formation during CNS 





1.4 The objective of the current study 
The role of JN in binding/regulating oligodendroglial cytoskeleton has been supported 
by the previous work in our lab: the colocalization of JN in the myelin sheath with 
CNPase, a known cytoskeleton-related oligodendroglial protein and its promoting 
arborization of cultured primary OLPs. Although JN is suggested as a 
cytoskeleton-related oligodendroglial protein, the exact and detailed relationship 
between Juxtanodin and cytoskeleton including the interaction and effect of 
Juxtanodin on oligodendrocyte cytoskeleton components such as actin remains to be 
elucidated.    
 
Furthermore, the specific location of Juxtanodin in oligodendrocyte and its coincident 
expression with MBP and CNPase at the OLs development stages suggests that JN 
may play roles in the maturation of oligodendrocyte and myelin formation. Hence, the 
effect of Juxtanodin on oligodendrocyte morphologies/behaviors such as migration 
and spreading is worth to be explored. It is also reasonably expected that the activity 
of Juxtanodin for cytoskeleton organization and oligodendroglia behaviors is 
precisely regulated by some mechanisms such as phosphorylation.   
 
The current study was conducted to investigate the ensuing topics: 
1. Studying the interaction of Juxtanodin with actin and its effects on actin dynamics 
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at the biochemical and cellular levels. 
2. Investigating the effects of Juxtanodin on actin-based cellular structures and 
behaviors, such as the formation of filopodia and stress fiber, cell spreading and 
migration. 
3. Illustrating the possible mechanisms for the regulation of Juxtanodin activity by 
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CHAPTER 2  
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2.1 Chemicals  
All chemicals were purchased commercially for research purpose. 30% acrylamide 
and bis-acrylamide solution (37.5:1), ammonium persulfate (APS), 
bromo-chloro-indolyl-galactopyranoside (X-gal), sodium dodecyl sulfate (SDS), 
N,N,N',N'-Tetramethylethylenediamine (TEMED), Triton-X-100 and Tween-20 were 
purchased from Biorad (Hercules, CA). EDTA, EGTA, magnesium chloride 
hexhydrate (MgCl2), potassium chloride (KCl), sodium chloride (NaCl) and all HPLC 
grade reagents (e.g. 1,2-Isopropanol, ethanol, glycerol and methanol) were all 
purchased from Merck (Darmstadt, Germany). 1,4-Dithiothreitol (DTT), 
4',6-diamidino-2-phenylindole (DAPI), ampicillium sodium, bromophenol blue, 
bovine serum albumin (BSA), deoxycholate, gentamicin, glycine, kanamycin sulfate, 
NP-40, ponceau s, select yeast extract and Tris base were all purchased from Sigma 
(St. Louis, MO). Paraformaldehyde was purchased from TAAB (England, UK). Fetal 
bovine serum (FBS), glutamine and low melting point agarose were purchased from 
Invitrogen (Carlsbad, CA).  
 
2.2 Oligonucleotides 
The primers for the construction or mutation of plasmids were designed using primer 
3 software and synthesized by Sigma (Singapore). The exact primer sequences for 
construction or mutation of corresponding plasmids referred to Table 2.1. 
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Plasmids Primers 










pXJ40-S278E 5’-agaattgatgagtttgaggaaatgatg cac-3’ 
5’-c tcaaactcat caattctctgtttggtgtt-3’ 
PET41a-6hisJNS278E 5’-agaattgatgagtttgaggaaatgatg cac-3’ 
5’-c tcaaactcat caattctctgtttggtgtt-3’ 
Table 2.1 The primer sequences for the construction or mutation of 
corresponding plasmids. 
 
2.3 Plasmids  
The ORF (open reading frame) of rat Juxtanodin was cloned from rat brain cDNA 
library by Polymerase Chain Reaction (PCR) technique and inserted into pET41a 
(Novagen, Germany). The PCR-amplified nucleotides 1-804 or 1-468 of rat JN ORF 
for the deletion mutants of JN absent of the last 14 or 112 amino acid at C-terminus 
respectively were inserted into pET41a for the expression of GST-tagged fusion 
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proteins. For ectopic expression in cultured cells, JN nucleotides were amplified by 
PCR from rat brain cDNA library and subcloned in between SmaI and KpnI sites of 
pXJ40-FLAG (Manser et al., 1997), generating FLAG-JN overexpressing vectors. 
The nucleotides 1-423 of rat JN ORF for the deletion mutant absent of the last 141 
amino acid at C-terminus was amplified by PCR and subcloned into Flag tagged 
pXJ40. The plasmids encoding dominant active RhoA (RhoV14) and the dominant 
negative RhoA (RhoN19), which are fused to the FLAG epitope, were gifts from 
Professor TANG Bor Luen, Department of Biochemistry, National University of 
Singapore. 
 
2.4 Cell lines 
Cell lines used in the experiments included OLN-93, Cos1 and CHO. OLN-93 cell 
line is a permanent oligodendroglia cell line derived from spontaneously transformed 
cells in primary rat brain glial cultures by  Richter-Landsberg and Heinrich (1996). 
In culture medium supplemented with 10% FBS, the doubling time of OLN-93 is 
determined to be about 16-18 hours. OLN-93 cells in culture are similar with primary 
oligodendrocytes on their antigenic properties. As revealed by the analysis of western 
blot and immunofluorescence, galactocerebroside and myelin-specific proteins, such 
as MBP, MAG, PLP and Wolfgram protein, are expressed although the surface 
marker of A2B5 is absent; OLN-93 cells do not express astrocyte-specific or 
neuron-specific protiens, such as glial fibrillary acidic protein (GFAP) and vimentin. 
For MBP, only a single isoform (approximate 14 kDa) is detectable in the cellular 
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extracts by western blot. RT-PCR reveals that the two mRNAs of PLP, DM20 and 
PLP, are present in OLN-93 cells. OLN-93 cells morphologically resemble bipolar 
O-2A- oligodendrocyte progenitor cells under normal culture conditions. However, 
when grown at low density or on poly-L-lysine-coated culture dishes under low 
serum conditions, they resemble immature oligodendrocytes with more arborized cell 
morphology. Staining of actin filaments with phalloidin is present at the cellular 
processes of OLN93 cells, while N-CAM/D2 immunoreactivity is detected on the cell 
surface of the somata and processes. In comparison with embryonic rat cerebral cells 
and primary oligodendrocytes in culture, OLN-93 cells resemble 5- to 10-day-old 
(postnatal time) cultured rat brain oligodendrocytes in their morphological features 
and their antigenic properties. OLN-93 cell line provides a useful model system to 
investigate the specific mechanisms regulating the proliferation and differentiation of 
oligodendrocytes in vitro, and the cellular interactions with other type cells of the 
CNS. 
 
COS-1 is a cell line belonging to the COS cell lines. The word COS is an acronym 
derived from the cells properties of CV-1 (simian) in Origin and SV40 genetic 
modification. Briefly, the COS cell line is derived by immortalization of a monkey 
kidney CV-1 cell line with insertion of SV40 genomical fragment, which could 
produce large T antigen (Gluzman, 1981). After the expression plasmids with the 
SV40 promoter are introduced into COS cells, the vectors can be replicated 
substantially by the large T antigen. COS is often used biologically for studying the 
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properties of monkey virus SV40 and producing eukaryotic recombinant proteins in 
mammalian cells for biochemistry, molecular biology and cell biology experiments. 
Cos1 cell line has been widely used in wound healing assay for examining the 
possible effect of genes on cellular migration (Chen et al., 2004; Huang et al., 2007), 
and it was also used for such a purpose in the current study. 
 
Chinese hamster ovary (CHO) cells are a cell line derived from the ovary of the 
Chinese hamster. They are often used in biological and medical research and 
commercially in the production of therapeutic proteins. Specially, RhoA GTPase has 
been well studied in CHO cells (Krall et al., 2002; Karpushev et al., 2010). 
DMEM/Ham's Nutrient Mixture F-12 (50:50) was used as a formulation for 
proprietary media for CHO cells.  
 
2.5 Molecular biology 
2.5.1 Polymerase chain reaction  
Polymerase chain reactions were used for selective amplification and modification of 
DNA (deoxyribonucleic acid) sequences in vitro. The amplification is based on 
repeated cycles of duplication of a DNA sequence between two short DNA 
oligonucleotides by a thermostable DNA polymerase. A typical 50 μl reaction was set 
up like this: 
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DNA-template 100 pg
DNA-polymerase (5 U/μl) 2 μl
dNTPs (10 mM) 1 μl
5´primer (5 μM) 2.5 μl
3´primer (5 μM) 2.5 μl
10x Polymerase buffer 5 μl
Aqua bidest Ad 50 μl
Typical program for PCR reactions: 
             Initial Denaturation       95 °C           5 min 
A 30 cycles of denaturation, annealing and elongation followed as: 
Denaturation 95 °C 30 sec
Annealing variable* 45 sec
Elongation 72 °C 1 min/kb
Final extension 72 °C 10 min
End 4 °C ∞
*The annealing temperatures of primers mainly depend on the length and the 
G/C-content of the oligonucleotides. 
 
2.5.2 Restriction and electrophoretic separation of DNA on agarose gels 
Plasmids or PCR products were cut site-specifically by restriction enzymes (Promega, 
USA) using buffer conditions and temperatures recommended by the manufacturer. 
5-10 U of restriction enzyme were used per microgram DNA. DNA was mixed with 
10× loading buffer, transferred to the gel and separated at 80 V by horizontal 
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agarose-gel electrophoresis. Dependent on the size of the DNA fragments, differently 
concentrated (0.5%-1.5%) agarose gels were used. DNA fragments were stained by 
SYBR@ Gold (Invitrogen, USA) and visualized using a transilluminator from Clare 
Chemical Research. Objective DNA bands were excised with a clean scalpel and 
purified using the QIAquick Gel Extraction Kit (Qiagen, Germany). 
 
2.5.3 Ligation of DNA 
DNA T4 ligase (Promega, USA) was utilized for the covalent ligation of restricted 
DNA fragments. 100 ng restriction-enzyme digested vector DNA was mixed with a 
2-5 molar excess of restriction-enzyme digested insert DNA in an end-volume of 10 
μl and ligated either over night at 16 °C or for 4 h at room temperature (RT) by 0.5 μl 
ligase in buffer conditions recommended by the manufacturer.  
 
TA cloning is achieved by the terminal transferase activity of some type of DNA 
polymerase, for example, the Taq polymerase. This enzyme is able to add a single 
3'-A overhang to each end of the PCR product. Therefore, the PCR product can be 
directly cloned into T-vector, a linearized cloning vector which has single 3'-T 
overhangs on each end. The complementary overhangs of the PCR product and a ‘T’ 
vector conduct to hybridization and the resulting recombinant plasmid is brought 
about by DNA ligase. For a typical TA cloning reaction, 50 ng T vector (Promega, 
USA) was mixed with a 2-5 molar excess of PCR product in an end-volume of 10 μl 
and ligated by DNA T4 ligase in conditions as mentioned above. 
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2.5.4 Transformation 
Chemically competent E. coli DH 5α and BL21(DE3) for transformation were 
prepared in our lab by CaCl2/MgCl2 method. Competent E. coli DH 5α or BL21(DE3) 
was thawed on ice. 10 ng plasmid DNA was given to 100 μl cells. After a further 
incubation time of 30 min on ice, DNA uptake was forced by a heat shock for 45 s at 
42 °C. Cells were placed back on ice for 1 min and 900 μl prewarmed, antibiotic-free 
LB or SOC medium were added. After growth for 45 min at 37 °C, 10 μl and 100 μl 
of cell suspension were plated on selective agar. 
 
2.5.5 DNA plasmid preparation 
Plasmid DNA was prepared with mini- and midi-preparation kits, following the 
protocols of the manufacturer (Qiagen, Germany). Plasmid concentrations were 
determined by spectrophotometer (Thermo Spectronic, USA) at 260 nm using 
Lambert-Beer Law. OD260/OD280 ratios were used to evaluate protein 
contamination.  
 
2.5.6 DNA sequencing 
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Terminator Ready Reaction Mix (Big dye) 4.0 μl 
Big dye buffer 4.0 μl 
Template 50-300 ng 
Primer (6.4 pM) 0.4 μl 
Aqua bidest Ad 20 μl 
Typical program for DNA plasmid sequencing: 
Initial Denaturation      96 °C       1 min 
A 25 cycles of denaturation, annealing and elongation followed as: 
Denaturation 96 °C 10 sec
Annealing 50 °C 5 sec
Elongation 60 °C 4 min
End   4 °C ∞
Extension products was purified as recommended by manufactures (ABI, USA) and 
sent to NUS MUMI sequencing facility for sequencing. 
 
2.5.7 Site-directed mutagenesis  
The plasmid, pXJ40-JN or PET41a-6hisJN, containing the full-length cDNA of 
Juxtanodin was used as a template to create a series of single point mutation (T258A, 
T258E, S278A and S278E) using the GeneTailor™ Site-Directed 
Mutagenesis System (Invitrogen, USA) according to protocal provided by the 
manufacturer. Briefly, wild-type plasmid, pXJ40-JN or PET41a-6hisJN, was firstly 
methylated by a DNA methylase provided in the kit. PCR was then performed with a 
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pair of primers (see the section of ‘2.2 Oligonucleotides’), the forward one of which 
was designed to carry the target mutation. These PCRs in this study were conducted 
with Platinum™ Taq DNA polymerase (Invitrogen, USA). Through these PCRs, 
linear double-stranded DNA products would be generated carrying the target 
mutations at the desired points. Subsequently heat shock transformation of these 
products into DH5αTM-T1R competent cells was performed. These competent cells 
could circularize the linear mutated PCR products, but at the same time digest to clear 
out methylated original wild-type plasmids because of the presence of McrBC 
endonuclease in the cells. Therefore, the colonies subsequently grow out would only 
be those carrying mutated forms of genes. The entire sequence of each mutant was 
verified by DNA sequencing. The workflow of site-directed mutagenesis conducted 
by GeneTailor™ site-directed mutagenesis system is showed in Figure 2.1. 
 
2.5.8 Western blot 
Principle: Western blot maybe is the most common protein analysis technique used 
in modern biomedical research. Western blot is widely used to directly identify, 
determine and monitor the relative amount of specific proteins in tissue or cell protein 
samples. Generally, a complex protein mixture (such as cell lyses, tissue extract) is 
separated on a SDS-PAGE gel by electrophoresis, then transferred to a nitrocellulose 
or polyvinylidene fluoride (PVDF) membrane for protein analysis. Primary antibodies 
are applied to detect specific protein antigens on the membrane. Detection of binding 
of antigen with antibody on a membrane is achieved using secondary antibodies, 
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which covalently link with biotin or a reporter enzyme such as alkaline phosphatase 
(AP) and horseradish peroxidase (HRP). The report enzymes are able to convert 
provided substrates either to the visible colored reaction products or to 
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Figure 2.1 Workflow of site-directed mutagenesis conducted by GeneTailor™ 
site-directed mutagenesis system. 
After Methylating plasmid DNA with DNA methylase, the plasmid is amplified in a 
mutagenesis reaction with a pair of overlapping primers, the forward one of which 
contains the target mutation. Through the PCRs, the linear double-stranded DNA 
product is generated to carry the desired mutations.  The mutagenesis mixture was 
transformed into DH5αTM-T1R competent cells for circularizing the linear mutated 
PCR products and digesting the methylated original wild-type template plasmid by 
the host cell. Only the unmethylated and mutated plasmid is left.  
 
Procedure: The protein samples were resolved by 10% SDS-PAGE and transferred 
to 0.45 µm PVDF membrane (Millipore, USA) using a semi-dry electrophoretic 
transfer cell (C.B.S Scientific, USA). After blocked by PBS-T-milk [PBS, 0.1% 
Tween 20, 5% non-fat blocking milk (BioRad, USA)] for 1 hour at RT, membranes 
were probed with primary antibody (polyclonal anti-Juxtanodin, made in house, 
1:1000) at 4 °C overnight. After the membranes were washed by PBST buffer (PBS 
and 0.1% Tween 20), they were incubated with alkaline phosphate-conjugated 
secondary antibody at RT for 1 hour. Immunodetection was conducted with CDP-Star 
chemiluminescent reagent (Roche, Switzerland).  
 
2.6 Biochemical methods 
2.6.1 Expression and purification of GST-tagged fusion proteins  
Different GST (Glutathione-S-Transferase protein)-fusion proteins for pull-down 
experiments and actin co-sedimentation assays were prepared during this work. 
JN268 and JN170 (Juxtanodin-170), which lacked the C-terminal 14 amino acid (aa) 
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or 112 aa of Juxtanodin, and the full-length Juxtanodin were subcloned in PET41a(+) 
vector (Novagen, Germany), which provide an N-terminal GST protein from 
Schistosoma japonicum as a tag. GST binds with high affinity to 
Glutathione-sepharose 4B (GSH) and in many cases increases the solubility of the 
fusion protein.  
 
The GST-fusion proteins were induced to expression in Escherichia coli strain 
BL21(DE3) CodonPlus-RIPL cells, which is deficient of bacterial protease systems, 
and were purified using Glutathione-Sepharose (Amersham Biosciences, UK) 
according to the instructions recommended by the manufacturer. In detail, the 
plasmids were transformed into BL21(DE3) competent cells by heat shock 
transformation. A single colony was selected from agar plates containing 50 mg/ml 
kanamysin and grown overnight in 5 ml luria broth (LB) medium containing 
kanamysin. On the next day, erlenmeyer flasks with 500 ml LB medium containing 
kanamysin were inoculated with 5 ml of the overnight bacteria culture and incubated 
in a rotary shaker at 37 °C. After the bacteria cultures reached an optical density of 
OD600=0.6-0.8, 0.4 mM isopropyl 1-thio-β-D-galactopyranoside (IPTG) was applied 
into the bacterial culture and cells were grown at 37 °C for additional 4 h to induce 
protein expression, then harvested by centrifugation for 30 min at 3,000 ×g using a 
Eppendorf 5804R centrifuge and a F-34-6-38 Rotor. After discarding the supernatant, 
the cell pellets were either frozen at -80 °C or the pelleted cells were directly lysed.  
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For purification of GST-tagged fusion protein, bacteria cells were resuspended in cold 
PBS and lysed on ice by sonication with the Fisher Scientific model 550 Sonic 
Dismembrator (10-12 pulses à 45 seconds) with full amplitude (100%) and intervals 
of 0.6 s. The cell lysate was centrifuged at 17,000 ×g for 30 min to pellet any 
insoluble contents. GSH beads was exhaustively washed by PBS and added to the 
supernatant of the ultracentrifugation step and incubated for 90 minutes on a rotary 
shaker at 4 °C. After binding, the soluble contents of the cell lysate with beads were 
loaded on a column and were washed thrice at 2 ml/min with 50 ml of PBS. Finally, 
GST-fusion proteins were then competitively eluted 1-3 times with 0.5-1 ml elution 
buffer containing of 20 mM free glutathione for at least 30 min for each elution step. 
The purified GST-fusion proteins were stored at -80 °C and identified by SDS-PAGE 
before the application.  
 
2.6.2 Expression and purification of polyhistidine-tagged fusion proteins  
Polyhistidine fusion proteins of Juxtanodin and its mutants were also created.  A 
Juxtanodin gene encoding 6 histidines at the N-terminus was constructed by PCR 
using the primers as listed in section of ‘2.2 Oligonucleotides’. All the resulting 
constructs were fully sequenced to assure that they were in correct reading frame 
before expression induction. 
 
Juxtanodin encoding the N-terminal polyhistidine extension was cloned into 
PET41a(+) by NdeI and XhoI (Promega, USA). The expression of 
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polyhistidine-tagged fusion proteins was conducted with the protocol as mentioned in 
the section of 2.8.1 and the proteins were purified according to standard protocols 
using Ni-NTA Superflow Cartridges (QIAGEN, Germany) with minor modification. 
In detail, bacteria cells collected after induction were lysed in cold PBS buffer and the 
supernatant of the ultracentrifugation was added on the Ni-NTA Superflow Cartridges 
which had been equilibrated with PBS buffer at 2 ml/min. After binding, the Ni-NTA 
Superflow Cartridges were washed 4 times with 10 volumes of Wash Buffer (pH 7.5, 
100 mM HEPES, 10 mM imidazole) and the polyhistidine-tagged fusion proteins 
were finally eluted 4 times with 0.5 volumes of Elution Buffer (pH 7.5, 100 mM 
HEPES, 500 mM imidazole). The purified polyhistidine-tagged fusion proteins were 
stored at -80 °C and identified by SDS-PAGE before the application.  
 
2.6.3 Purification of GST and GST-JN protein by gel filtration FPLC 
The further purification of GST and GST-JN for in vitro biochemical assays was 
achieved by gel filtration as followed. The preliminary purified GST/GST-JN was 
applied to the pre-prepared Superdex G75 gel filtration column (Amersham 
Pharmacia Biotech, UK), eluted with Tris-HCl (pH 7.4, 50 mM) at a flow rate of 1 
ml/min. The absorbance was monitored at 280, 254 and 215 nm simultaneously.  
 
2.6.4 Buffer-exchange by cut-off centrifugal filters 
The purified proteins were buffer-exchanged to general actin buffer (5 mM Tris-HCl, 
pH 8.0 and 0.2 mM CaCl2) using 10 kDa molecular weight cut-off Amicon Ultra 
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centrifugal filters (Millipore, USA). To buffer exchange, the samples were spun with 
5,000 ×g at RT and the concentrated proteins were reconstituted with general actin 
buffer. Each cycle changes 90% of buffer. Typically, five spins will completely 
change to desired buffer. Prior to an experiment, proteins were pre-clarified at 
160,000 ×g, checked for correct size by SDS-PAGE analysis, and their concentrations 
were determined by BCA protein assay. 
 
2.6.5 BCA protein assay 
Protein concentrations were determined by BCA (bicinchoninic acid) protein assay 
(Pierce, USA). The assay was performed in an end-volume of 200 μl containing 10 μl 
protein standard or sample. After mixing by pipetting, the mixtures were incubated 
for 30 min at 37 °C. The bicinchoninic acid reagent forms colorimetric complexes 
with Cu+1, which is reducted from Cu+2 by protein in an alkaline medium, leading to a 
shift of the light absorbance maximum to 562 nm. This increase in absorption at 562 
nm was measured by spectrophotometer (Thermo Spectronic, USA). BSA with 
different concentrations from 0.025 mg/ml to 2.5 mg/ml was used as standards. 
 
2.6.6 Actin filament co-sedimentation assay 
Principle: The principle of actin filament co-sedimentation assay is described as 
follows. Actin co-sedimentation assay is an in vitro method mostly to investigate the 
F-actin binding ability of interested proteins. Its basic procedure involves incubation 
of the interested protein with F-actin, ultracentrifugation to precipitate F-actin in the 
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pellet and analysis of the protein co-precipitated with F-actin. In detail, F-actin is 
separated from G-actin by ultracentrifugation because of their differential 
sedimentation. F-actin binding proteins will co-precipitate with actin filaments in the 
pellet. Actin co-sedimentation assays can also be performed to measure actin binding 
affinities by competition assays. Non-actin binding proteins, G-actin binding proteins 
or F-actin severing proteins will remain in the supernatant. Severing proteins will be 
expected if more G-actin is present in the supernatant than in the negative control, 
and the activity of severing should be further examined by measuring distributions of 
F-actin length before and after adding the tested protein. G-actin binding proteins can 
be tested by adding the protein to G-actin before inducing polymerization; if the 
protein has the activity of sequestering G-actin, more actin will remain in the 
supernatant compared with the control after ultracentrifugation. When carrying out 
F-actin co-sedimentation assay, a number of points should be considered, for example, 
pH and temperature. The buffer components for the incubation and salt concentration 
may also affect the binding of the test protein to F-actin.  
 
Procedure: The F-actin binding ability of Juxtanodin and truncated Juxtanodin were 
measured using centrifugation conditions that pellet F-actin. Actin filament 
co-sedimentation assay was also used to detect the F-actin stabilizing ability of 
polyhistidine tagged JN WT and JNS278E mutant. The procedure of actin filament 
co-sedimentation assay is described as followed. In the present study, actin isolated 
from human platelets (β-actin) or rabbit skeletal muscle (α-actin) (Cytoskeleton, 
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USA) was used. Stock aliquots of actin at the concentration of 1 mg/ml were kept in 
the -80 ºC freezer and the actin sample was diluted to 0.4 mg/ml in general actin 
buffer and centrifuged at 20,000 ×g for 10 min at 4 ºC before use. The supernatant, 
which was G-actin, was ready to be polymerized and actin polymerization was 
induced by the addition of 10×F-actin buffer. The polymerization occurred at RT for 
1 hour. The GST or polyhistidine fusion proteins used in the assay were spun at 
100,000 ×g to pre-clear of aggregates in a Beckman ultracentrifuge at RT for 20 min 
and then were added to polymerized actin in a total volume of 50 µl F-actin buffer (5 
mM Tris-HCL pH 8.0, 0.2 mM CaCl2, 50 mM KCL, 2 mM MgCl2 and 1 mM ATP) 
(Cytoskeleton, USA) in ultracentrifuge tubes. The samples were incubated at RT for 
30 min to allow for interaction between the fusion proteins and F-actin. Negative 
control reactions containing all the components of the assay except F-actin or GST 
fusion proteins were performed in parallel. Following the incubation, the samples 
were spun at 100,000 ×g at 22 ºC using a Beckman ultracentrifuge. After incubation, 
the samples were centrifuged at 160,000 ×g for 1.5 h at room temperature in a 
TLA-100.3 rotor in a Beckman Optima L-90K ultracentrifuge. For actin 
depolymerization study, F-actin pellet alone or in the presence of polyhistidine tagged 
JN WT or JNS278E mutant was resuspended at 2 µM in G buffer (5 mM Tris-HCl, 
pH 8.0, 0.2 mM CaCl2 and 1 mM ATP) at RT. After 3 hours, the samples were 
ultracentrifuged as described above. The supernatants were carefully transferred by 
pipetting into eppendorf tubes so as not to disturb the pellets and 5×SDS sample 
buffer was added. The remaining pellets were solubilized in an appropriate volume of 
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1×SDS sample buffer and transferred to new eppendorf tubes. Equal volumes of 
pellet and supernatant were resolved by SDS-PAGE gel and analyzed by Coomassie 
blue staining. 
 
2.6.7 F-actin bundling assay  
Proteins with F-actin bundling activity can be determined by F-actin bundling assay, 
the procedure of which is similar with the F-actin co-sedimentation assay except of 
the lower centrifugal speed (15,000 ×g vs 150,000 ×g) because F-actin bundling 
protein makes the F-actin to form bundles. For F-actin bundling assay, excessive 
Juxtanodin was incubated with ~6.5 µM β-actin in a total volume of 50 µl of F-actin 
buffer for 30 min at RT and centrifuged in an Eppendorf centrifuge at 15,000 ×g for 
15 min to sediment bundled actin filaments. Equal volumes of pellet and supernatant 
were solubilized in SDS-PAGE sample buffer and analyzed by Coomassie blue 
staining. 
 
2.6.8 Fluorescent measurement of actin assembly  
Purified rabbit skeletal muscle actin (Cytoskeleton, USA) has been covalently linked 
with pyrene at the cysteine 374 residue. N-(1-pyrene) iodoacetamide could be used 
for detection of the modified actin protein. The stoichiometry of pyrene labeling is 
determined as 6 dyes for 10 actin monomers. This molecular weight of pyrene 
modifed actin is about 43 kDa. The protein was delivered as a white lyophilized 
powder and reconstituted to 1 mg/ml in general actin buffer for stock aliquots before 
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kept in -80 ºC freezer. Before use, the proteins was thawed and subjected high speed 
centrifugation at 150,000 ×g to pre-clear of aggregates in a Beckman ultracentrifuge 
at RT for 20 min.  
 
The effect of GST-JN and GST on the rate and extent of polymerization of β-actin, 
which was mixed with pyrene-labelled rabbit skeletal muscle actin as a ratio of 10:1, 
was determined. 9 μM of actin was polymerized alone or in the presence of either 
GST-JN or GST. The increase in fluorescence was monitored in a Fluorometer of 
SpectraMAX Gemini EM (Molecular Devices, USA) with excitation and emission at 
365 and 407 nm respectively, over approx. 30 min.  
 
2.7 Cellular biology 
2.7.1 Cultivation of cells 
Cells were cultivated in cell-culture flasks (75 cm2 or 25 cm2) at 37 °C, 90% humidity 
and 5% CO2. OLN-93 and Cos1 cells were cultivated in DMEM (dulbecco’s 
modified Eagle’s medium) supplemented with 10% FBS. Cells were passaged at 
~80% confluence and diluted 1:10. For cryoconservation, cells were collected by 
centrifugation (1000 ×g, 5 min, RT), resuspended in sterile FCS (106 cells in 900 μl) 
followed by slow addition of 100 μl sterile dimethyl sulfoxide (DMSO). Cells were 
stored at -20 °C in a styropor-box overnight, transferred to -80 °C for another day and 
then frozen in liquid nitrogen. Frozen cells were thawed quickly at 37 °C in a water 
bath and immediately transferred into a sterile Falcon-tube containing 10 ml of 
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growth medium. Cells were collected by centrifugation (1000 ×g, 5 min, RT) and 
plated after resuspension in an appropriate volume of growth medium. 
 
2.7.2 Transfection  
2.7.2.1 Electroporation of OLN-93 and CHO cells  
In the studies to test the effect of Juxtanodin on OLN-93 cellular morphology and 
actin reorganization or the effect of RhoA GTPase on JN activity in CHO cells, cells 
were transfected by using MP-100 Microporator (Digital Bio Technology, South 
Korea). For transfection, cells on ~80% confluence were washed with Ca2+-free PBS 
and detached from flasks by trypsin. Cells were mixed with DMEM supplemented 
with 10% FBS and the densities were calculated with hemacytometer. 105 cells 
resuspended in buffer R and combined with 0.5 μg plasmids were used for one shoot 
using the 10 μl golden tip. Three crucial parameters of pulse voltage, width and pulse 
numbers were appointed as 1400 V, 20 ms and 2 times for electroporation of cells. 
After transfection, cells were fixed with 3% paraformaldehyde for 
immunofluorescence studies. 
 
2.7.2.2 Chemical transfection of Cos1 cells with Lipofectamine 
Cos1 cells were kept growing on coverslips until ~50% confluence. They were then 
transfected by the plasmids with Lipofectamine 2000 (Invitrogen, USA). The 
transfection method with Lipofectamine 2000 was slightly modified, in comparison to 
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manufacturer’s instruction. We added 0.8 μg plasmid instead of 1 μg into each well of 
6-well plate and the buffer volumes for each well were also proportionally decreased.  
 
2.7.3 Treatment of OLN-93 cells with Latrunculin A 
Latrunculins are natural toxins which are widely used in modern biomedical research 
on actin. The name of Latrunculin is inspired from its production from certain 
sponges including genus Latrunculia. Latrunculins bind to G-actin near the site for 
nucleotide binding at the ratio of 1 to 1 and prevents them from polymerization in 
vitro (Morton et al., 2000) and in vivo (Spector et al., 1983).  The crystallographic 
structure of Latrunculin A (LatA), a member of Latrunculins family, in the status of 
being free or binding to actin has been figured out (Morton et al., 2000). The binding 
site of Latrunculin A is located between subdomains 2 and 4 of G-actin. Tyrosine 69, 
threonine 186 and arginine 210 of G-actin are the exact amino acids responsible for 
the binding with Latrunculin A, in consistence with the investigation determining the 
binding sites by mutagenesis-based screening (Belmont et al., 1999). Latrunculins 
bind to G-actin with the competition of thymosin b4 but independently to profilin and 
DNase I (Yarmola et al., 2000). The chemical modulation of Latrunculin A is shown 
in Fig. 2.2. 
 
The procedure of treatment of OLN-93 cells with Latrunculin A is described as 
followed. At 48 hours after JN transfection, OLN93 cells were further cultured in the 
presence of Latrunculin A. To treat OLN93 with LatA, we applied a concentrated 
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stock of LatA (Sigma Aldrich, USA) in prewarmed DMEM to the wells at the final 
concentration of 0.5 μM or 0.25 μM. Given that FBS could interfere with the function 
of LatA (Kuriu et al., 2006), FBS was reduced to a low concentration (1%) in the 
culture medium from the beginning of adding LatA. After another 4 hours culture in 




Figure 2.2 The chemical structural formula of Latrunculin A. 
Latrunculin A binds to G-actin at the ratio of 1 to 1. In consistence of its biding to 
G-actin between subdomains 2 and 4, namely near the nucleotide-binding cleft, it 
inhibits nucleotide exchange of G-actin, induces structure alteration of G-actin and 
finally prevents actin polymerization (Yarmola et al., 2000; Morton et al., 2000). 
 
2.7.4 Immunocytochemistry (ICC)  
Principle: Immunocytochemistry is a method for figuring out the localization of 
specific antigens in cells on account of the specific binding of antigen and antibody. A 
series of technical developments in ICC have created sensitive detection systems and 
the most commonly used are the enzyme-labeled, fluorescent dye-labeled, or 
electron-dense particles-labeled for light microscope, fluorescence microscope and 
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electron microscope observation respectively. To achieve greater sensitivity is a 
critical issue for ICC studies and a large number of detection techniques have been 
developed, including avidin-biotin conjugate (ABC), peroxidase antiperoxidase (PAP) 
and biotin-streptavidin (B-SA) methods. 
 
The routine procedure for ICC study includes fixation, blocking, the primary antibody 
incubation and detection. Fixation is required to stabilize the cells and protect them 
from the rigors of subsequent processing and staining steps. Blocking of nonspecific 
background staining enhances the specificity of the primary antibody. Antibody 
molecules are labeled or flagged to permit their visualization.  
 
Procedure: For ICC studies, OLN-93 cells or Cos1 cells were fixed with 3% 
paraformaldehyde at forty-eight hours after transfection. After blocked with 
PBS-T-NGS [(1×PBS, 0.3% Triton X-100 and 6% NGS (normal goat serum)], the 
cells were incubated with primary antibody (monoclonal anti-FLAG, Sigma, 1:1000 
or polyclonal anti-Juxtanodin, made in house, 1:100) at RT for overnight. A 
secondary antibody covalently linked with Alexa Fluor 488 or 568 (Molecular Probe, 
USA) was used for detecting the primary antibody. Appropriate controls are needed 
for the confirming the specificity of primary antibody. Theoretically, these controls 
include no-primary-antibody control (a control in which the tissue is incubated with 
antibody diluent, without the primary antibody included), absorption control (a 
control in which primary antibody pre-incubates with the immunogen before its 
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application for ICC), positive control (a section from a cell line known to express the 
target protein) and negative control (a section from a cell line known not to express 
the target protein). The specificity of JN antibody had been verified preciously 
(Zhang et al., 2005). Moreover, because OLN-93 and Cos1 cells do not express 
FLAG or Juxtanodin under the culture condition, the non-transfected cells were 
expected to be fluorescence-signal-negative after ICC procedures, which actually 
could be used as negative controls for confirming antibodies specificity in these 
experiments. Rhodamine-conjugated phalloidin (Cytoskeleton, USA) was used for 
detecting F-actin as instructed by the manufacturers. After wash with PBS, fixed cells 
were routinely stained for 15 minutes with 200 ng/ml DAPI solution before being 
mounted and analyzed. 
 
2.7.5 Wound healing assay  
Principle: The principle of wound healing assay in the current study is described as 
followed. Wound healing assay could study cell migration straightforwardly and 
economically in vitro. It is established on the observation that, after creating an 
artificial gap, called "scratch", on a confluent monolayer cells, the cells on the gap 
edges move toward the opening until to the "scratch" is closed. Briefly, the basic 
steps for would healing assay include scratching monolayer cells to create a opening, 
capturing images during cells move toward the opening and comparing the images to 
determine the cell migration rate. Wound healing assay is useful for studying the 
migration behavior of certain cell type and the role of specific extracellular matrix 
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(ECM) in cell migration. Additionally, it allows investigation of the intracellular 
events in live migrating cells. For example, combined with the microscope for 
imaging live cells, would healing assay could detect the subcellular location of the 
green fluorescent protein (GFP)-tagged interested proteins or investigate the 
protein–protein interaction by fluorescent resonance energy transfer (FRET) during 
cell migration. Moreover, wound healing assay is yet the simplest way to investigate 
cell migration in vitro and the researcher just need the common supplies to conduct it. 
Although it is established to study the migration of cell population, wound healing 
assay has also examined the effects of exogenously expressed proteins on individual 
cell migration (Etienne-Manneville et al., 2001; Abbi et al., 2002). The migration 
track of the individually transfected cell could be compared with neighboring cells 
and that of the control group to determine the effect of certain interested protein on 
the cell migration.  
 
Procedure: The procedures of wound healing assay in this study are described as 
followed. Cos1 cell line has been widely used in wound healing assay for examining 
the possible effect of targeted genes on cellular migration (Chen et al., 2004; Huang 
et al., 2007) and it was also applied here to investigate JN’s role in cellular migration. 
80% confluent growing Cos1 cells were washed twice with Ca2+-free PBS and 
detached from tissue culture flasks by trypsin. Cells were mixed with DMEM 
supplemented with 10% FBS and the densities were calculated with hemacytometer 
before seeded in the 6-well plate. Cultivated Cos1 cells on 50-60% confluence were 
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transfected with the constructs directing the expression of GFP, the FLAG 
epitope-tagged wild type JN or JN141 (Juxtanodin-141, a truncated JN protein 
containing the N-terminal 141 amino acids) proteins. The plates were incubated for 
twenty-four hours at 37 °C until cells reach 100% confluence to form a monolayer. A 
scratch was created on the Cos1a cell monolayer using a 200 μl plastic pipet tip and 
the wells were washed and replaced with DMEM containing 5% FBS. Phase-contrast 
were acquired before cells migrate to the opening scratch and fluorescence images for 
the individually transfected cells were taken after forty-eight hours later. The 
migration rate of JN-expressed cells was compared with that of surrounding cells and 
that of JN141-expressed or GFP-expressed cells in control groups. 
 
2.8 Statistical analysis 
All experiments were repeated for at least two times to verify the results. SDS-PAGE 
gels were scanned with a GS-710 calibrated imaging densitometer (Bio-Rad, USA) 
and the densitometric analyses were performed using Image J software. The pictures 
of immunofluorescence studies were captured with a laser-scanning confocal 
microscope (Olympus, Japan). Cellular F-actin content was calculated by multiplying 
the mean OD (after subtracting background) of rhodamine-conjugated phalloidin 
staining with the cellular area. Statistical analyses for the present experiments were 
carried out by unpaired Student’s t-test using the statistical software of GraphPad 
Prism 4. The statistical results were presented as mean ± SEM and the data, the value 



























3.1 The role of Juxtanodin in actin dynamics 
3.1.1 Juxtanodin specially bound F-actin 
Actin exists in two different forms: G-actin, namely globular actin, is the monomeric 
form that can assemble into the polar, filamentous form: F-actin. Although the 
previous immunoprecipitation assay (Zhang et al., 2005) in our lab revealed that JN 
interacted with actin in vivo, it still remains illusive which actin form JN bound and 
whether their interaction was mediated by other proteins. Therefore, the ability of 
Juxtanodin to bind G-actin and F-actin was explored by biochemical assays. G-actin 
pulldown assays in our lab showed that Juxtanodin could not bind G-β-actin in vitro 
(data not shown). Furthermore, we examined the ability of Juxtanodin to bind F-actin. 
The ability of WT GST-JN proteins for F-actin binding was examined by F-actin 
co-sedimentation assays. Small amount of GST fusion proteins were incubated with a 
constant amount of polymerized F-β-actin and the filaments were pelleted by 
ultracentrifugation. Actin filaments longer than 10 subunits in length will sediment 
under these conditions (Attri et al., 1991). As shown in Fig. 3.1, almost all actin 
sedimented in the pellet, indicating their effectively assembling into the filamentous 
form in the polymerization condition. As a negative control, GST protein was not 
recovered in the pellet with actin. However, considerably high amounts of GST fused 
WT JN obviously co-sedimented with pre-polymerized F-actin. In contrast, the 
GST-JN protein remained soluble and did not sediment by itself in a control sample 
without F-actin. It was also apparent that GST-JN did not affect the amount of β-actin 
that sedimented. α-Actinin, a known actin-binding protein that decorates actin 
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filaments side-wise, was used as a positive control here. 
 
Figure 3.1 Juxtanodin bound F-actin in vitro.  
The ability of JN binding to F-β-actin was investigated by F-actin co-sedimentation 
assay. GST-JN, positive control α-actinin, or negative control GST was incubated in 
the presence (+) or absence (-) of pre-polymerized F-β-actin suspension. The mixtures 
were then ultracentrifuged, and the supernatants (S) and pellets (P) were analyzed by 
SDS-PAGE and staining with Coomassie Blue. Each S and P represent the soluble 
and pellet fractions from the same sample. The positions of various proteins are 
indicated by arrows on the right. Molecular mass markers in kDa are indicated on the 
left. An asterisk marks possible C-terminal degradation products from the full-length 
GST-JN fusion protein. 
 
3.1.2 JN interacted with F-actin through the last C-terminal 14 amino acid 
residues 
Furthermore, the functional domain of JN in charge of F-actin binding was identified 
by the F-actin co-sedimentation assay using a series of GST-JN truncated proteins. 
GST-JN268 and GST-JN170, deletion of the last 14 and 112 amino acid residues 
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respectively, were applied in this study and their ability of binding F-actin was 
compared to that of JN. As shown in Fig. 3.2, considerable amount of GST-JN 
expectably co-sedimented with pre-polymerized F-actin. Under the same condition, 
however, GST-JN268 mostly remained in the supernatant, suggesting a critical role of 
the C-terminal 14 amino acid residues of JN in its F-actin binding. Deletion of the last 
112 amino acid of JN (GST-JN170) eliminated the F-actin binding property of JN 
completely (Fig. 3.2).  
 
 
Figure 3.2 Mapping the C-terminal 14 amino acid residues of JN as the F-actin 
binding domain.  
The ability of the truncated GST-JN proteins binding to F-β-actin was investigated by 
F-actin co-sedimentation assay. GST-JN170, GST-JN268 or GST-JN was incubated 
in the presence (+) or absence (-) of pre-polymerized F-β-actin suspension. The 
mixtures were ultracentrifuged, and the supernatants (S) and pellets (P) were analyzed 
by SDS-PAGE and staining with Coomassie Blue. Each S and P represent the soluble 
and pellet fractions from the same sample. The positions of various proteins are 
indicated by arrows on the right. Molecular mass markers in kDa are indicated on the 
left. An asterisk marks possible C-terminal degradation products from the full-length 
GST-JN fusion protein. 
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Additionally, it was observed that two protein bands were always detected in the 
different batches of prepared GST-JN fusion proteins (e.g. Fig. 3.1 and Fig. 3.2). 
Whereas the upper band protein, which was in the size of deduced GST-JN molecular 
weight, could completely precipitate with F-actin, the protein of low band mostly 
remained in the supernatant, suggesting that it had no binding activity with F-actin. 
Some chaperone proteins such as heat shock protein have been reported to be 
occasionally present in the purified proteins (Lara et al., 2005). To check the 
possibility of the low band protein as a chaperone associated with GST-JN purified 
from bacteria, western blot against Juxtanodin were performed. The western blot 
assay revealed two close but obviously different bands (Fig. 3.3A), suggesting that the 
protein of low band was a product of induced GST-JN proteins but not the chaperone 
protein. The further study for extensively separating the two bands of GST-JN on the 
SDS-PAGE gel of high concentration (12%) showed that the position of GST-JN268 
truncated protein was higher than that of the low band protein of GST-JN (Fig. 3.3B). 
Taken together, it was suggested that the protein of the low band in the purified 
GST-JN was most possibly a product degraded by some protease from bacteria during 
purification (Jonasson et al., 2002), which lost more than 14 amino acids of 











Figure 3.3 The protein of low band in the purified GST-JN was possibly as a 
C-terminal degradation product.  
A. Western blot against Juxtanodin were performed with purified GST-JN proteins. 
An asterisk marks the low band of purified GST-JN proteins. B. The purified 
GST-JN268 and GST-JN proteins were analyzed by SDS-PAGE (12%) and staining 
with Coomassie Blue. 
 
3.1.3 Juxtanodin exhibited isoform preference of actin binding 





(Rozycki et al., 1991; Yao et al., 1996). To determine whether JN binds to actin 
filaments in an isoform-specific manner, we assayed the ability of JN to co-sediment 
with skeletal muscle α-actin and platelet β-actin by actin filament co-sedimentation 
assay described as above. Following ultracentrifugation, the amount of JN associated 
with the actin filaments pellet was measured by SDS-PAGE. The Coomassie blue 
staining in Fig. 3.4 showed that GST-JN pelleted poorly when incubated with 
F-α-actin. Under the same experimental condition and with the same amounts of 
starting materials, the amount of F-β-actin-bound GST-JN was approximately 2-fold 
higher when compared with that bound to F-α-actin. α-actinin was used as a control 
for the confirmation of the quality of α-actin (Fig. 3.4). 
 
 
Figure 3.4 Juxtanodin exhibited isoform preference on β-actin for its F-actin 
binding ability.  
Binding specificity of JN to skeletal muscle α-actin and platelet β-actin was tested by 
F-actin co-sedimentation assay. GST-JN was incubated alone (-) or in the presence of 
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pre-polymerized F-β-actin or F-α-actin suspension. The mixtures were 
ultracentrifuged, and the supernatants (S) and pellets (P) were analyzed by 
SDS-PAGE and staining with Coomassie Blue. Each S and P represent the soluble 
and pellet fractions from the same sample. α-actinin was adopted for the confirmation 
of the quality of α-actin here. The positions of various proteins are indicated by 
arrows on the right. Molecular mass markers in kDa are indicated on the left. An 
asterisk marks possible C-terminal degradation products from the full-length GST-JN 
fusion protein.  
 
3.1.4 Juxtanodin had no activity of bundling or cross-linking   
Actin bundles are actin filaments cross-linked into closely-packed parallel arrays. The 
formation of actin bundles requires the presence of actin-cross linking proteins 
(Winder, 2003). In general, the crosslinking proteins that form actin bundles are 
smaller, globular proteins such as a-actinin, fimbrin and fascin (Otto, 1994). To 
determine whether Juxtanodin acts as an actin-crosslinking protein, recombinant 
GST-JN was incubated with F-β-actin. The samples were then subjected to low speed 
centrifugation that could sediment bundled actin filaments. The result showed that 
GST-JN was ineffective in precipitating F-actin under low speed centrifugation even 
at excessively high concentration (Fig. 3.5). As positive controls, actin and a-actinin 
were found together in the low speed pellet while the actin filaments remained in the 
supernatant fraction in the absence of a-actinin, indicating the induction of actin 





Figure 3.5 Juxtanodin had no activity of bundling or cross-linking.  
The ability of JN bundling or cross-linking F-β-actin was investigated by F-actin 
bundling assay. Pre-polymerized F-β-actin was incubated alone or allowed to react 
with GST-JN or α-actinin (a positive control here) in F buffer for 30 min and 
sedimented at 15,000 ×g for 15 min. Under this condition, the linear, unbundled 
F-actin stays in supernatant but bundled F-actin sediments. Both supernatant (S) and 
pellet (P) were separated on SDS/PAGE and staining with Coomassie Blue. The 
positions of various proteins are indicated by arrows on the right. Molecular mass 
markers in kDa are indicated on the left.  
 
3.1.5 Juxtanodin could not promote actin polymerization  
To assess the role of Juxtanodin in actin polymerization, polymerization assays 
monitored by fluorescent measurement were conducted. Pyrene fluorescence 
increases when a pyrene-labeled actin subunit is incorporated into a polymerizing 
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filament (Cooper et al., 1983). Because Juxtanodin was found to have isoform 
preference for β-actin binding, pyrene-conjugated α-actin, which is commercially 
available, was mixed with β-actin at 1:10 ratio. With the extreme majority of β-actin, 
the reaction mixture could simulate the polymerization of β-actin, therefore it is 
widely used for the studies on β-actin-binding proteins (Duncan et al., 2001; 
Wahlström et al., 2001; Balcer et al., 2003). To increase the sensitivity of 
polymerization assay by reducing the starting background fluorescence, the samples 
were centrifuged at 160,000 ×g for 2 hours at 4 °C before induction of polymerization. 
β-actin with pyrene-conjugated α-actin readily polymerized when KCl and MgCl2 
were included as demonstrated by the standard curve (Fig. 3.6). However, we did not 
detect any alteration in the rate and extent of actin polymerization in the presence of 
GST-JN compared with in the presence of GST. GST tagged JN seemed to neither 
modulate the lag associated with the nucleation phase nor influence the filament 
elongation phase as evidenced by the same rate of assembly at and after the initial lag 
phase (Fig. 3.6), indicating that Juxtanodin did not act as an sequestering, nucleating, 




Figure 3.6 Juxtanodin could not promote actin polymerization.  
The effect of Juxtanodin on actin polymerization was investigated by fluorescent 
measurement. Monomeric β-actin mixed with pyrene-labeled rabbit skeletal muscle 
actin as a ratio of 10:1 in general actin buffer was polymerized in the presence of 
GST-JN (yellow line) by adding 1/10th volume of actin polymerization buffer. 
Polymerization was monitored as an increase in fluorescence intensity as described in 
MATERIALS AND METHODS. As controls, the incubation was carried out alone 
(blue line) or in presence of GST (pink line). 
 
3.1.6 Juxtanodin inhibited actin depolymerization in vitro 
We next analyzed the potential of JN to inhibit F-actin disassembly. Since GST can 
form dimer and then perform potentially undesirable effects on the disassembly 
activity of JN (Singh et al., 1987; Chang et al., 1990), we addressed this issue with 
polyhistidine tagged JN using the method previously described by Rybakova et al. 
(1997). The F-actin disassembly was induced by dilution into low salt buffer 
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conditions, and the effect of polyhistidine tagged JN produced in E. coli on actin 
disassembly was examined using actin co-sedimentation assay. At 180 min after 
dilution with the F-actin depolymerization buffer, 8.8% of actin remained in the 
high-speed centrifuged F-actin pellet in the actin alone group, while 15.2% actin was 
pelleted in the experimental group preincubated with polyhistidine tagged JN (Fig. 
3.7), indicating Juxtanodin significantly protected F-actin from depolymerization 
under this condition. 
 
Because a potential phosphorylation site of Juxtanodin, serine 278, is located in the 
F-actin binding region (Shu et al., 2004), we examined whether phosphorylation of 
this site might influence the ability of JN on F-actin stability. JN was mimicked to the 
phosphorylation status at this site by site-directed mutation of serine 278 to glutamine 
(Korotchkina et al., 2001; Aslam et al., 2010). The polyhistidine tagged JN mutant 
(6his-JNS278E) was used to examine its effect on actin depolymerization by the 
above F-actin sedimentation assay. In the presence of 6his-JNS278E, the 9.6% 
retention of F-actin in the high speed-pelleted portion at 180 minutes into the 
depolymerization reaction was almost the same as compared to the 8.8% retaining 
rate in the F-actin alone control group (Fig. 3.7). These results suggest JN could 
inhibit F-actin disassembly; phosphorylation of JN at serine 278, however, directly 





Figure 3.7 Actin filament co-sedimentation assay showed F-actin-stabilizing 
ability of polyhistidine-tagged JN, but not JNS278E mutant.  
Pre-polymerized F-β-actin was incubated alone (-) or in the presence of polyhistidine 
tagged JN or JN278E before the mixtures were ultracentrifuged, then the F-actin 
pellets were induced to depolymerization by being resuspended in G-buffer. After 3 
hours of depolymerization, the samples were ultracentrifuged and the pellets were 
analyzed by SDS-PAGE and staining with Coomassie Blue staining. The positions of 
various proteins are indicated by arrows on the right, whereas molecular mass 
markers in kDa on the left. 
 
3.1.7 Juxtanodin increased F-actin content of OLN-93 cells 
The actin cytoskeleton in living cells is in a dynamic condition, which means actin 
polymerization and depolymerization simultaneously occurs to spatiotemporally 
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coordinate actin-based cellular structures and behaviors. Given that Juxtanodin 
prevented F-actin disassembly in vitro, the effect of JN on F-actin content increase in 
living cell was expected and investigated by immunofluorescence study. The intensity 
of F-actin revealed by rhodamine-conjugated phalloidin staining in FLAG-JN 
overexpressors was compared with that of neighboring cells (Fig. 3.8A), and the ratio 
of the two values was used to plot possible changes in relative F-actin levels and 
evaluate the effect of JN on F-actin content in vivo. The statistical result showed that 
the content of F-actin in FLAG-JN overexpressors was significantly augmented 
(average 317 ± 31% of neighboring untransfected cells; n = 28 for JN transfectants 
and 119 for neiborning untransfected cells; 7 representative fields were counted) (Fig. 
3.8B). Together, these results suggested that in consistence with its role in preventing 
actin depolymerization at biochemical level, JN also stabilized F-actin in living cells, 
leading to the increase of cellular F-actin content. Notably, the mean OD of F-actin 
staining was not significantly increased in the presence of JN in cells. It suggested 
that the increase of total cellular F-actin by JN augmented the cellular volume but not 










Figure 3.8 Juxtanodin increased F-actin content of OLN-93 cells.  
A. OLN93 cells expressing exogenous FLAG-JN were visualized by 
immunofluorescence using anti-JN antibody (green) and the F-actin content of 
FLAG-JN-transfected cells or neighboring non-transfected control cells was revealed 
by staining with rhodamine-conjugated phalloidin (red). Compared with neighboring 
non-transfected control cells, FLAG-JN-transfected cells showed increased F-actin 
content. Scale bar: 50 μm. B. Quantification of F-actin content of 
FLAG-JN-transfected OLN93 cells (n = 28) and neighboring untransfected cells (n = 
119). F-actin content was calculated by multiplying the mean OD of 
rhodamine-conjugated phalloidin staining with the cellular area, which was measured 
using Image J software and the ratio between FLAG-JN-expressing cells and 
neighboring untransfected cells was generated as measure for the relative F-actin 





3.1.8 Juxtanodin inhibited F-actin disassembly induced by Latrunculin A 
Furthermore, the effect of Juxtanodin on antagonizing the F-actin disassembly of 
cultured cells was further explored. Latrunculins promote F-actin depolymerization by 
binding to G-actin at the site adjacent to the nucleotide-binding cleft, which prevents 
the re-incorporation of actin into filaments and depletes cellular F-actin over time 
(Coué et al., 1987). In the present study, Latrunculin A was used for disassembling 
F-actin of OLN-93 cells. At 48 hours after electroporated with FLAG-JN, OLN-93 
cells were incubated in the presence of Latrunculin A at the concentrations of 0.25 
uM or 0.5 uM for another 4 hours to induce F-actin disassembly. Given that FBS 
could interfere with the function of Latrunculin A, FBS was reduced to a low 
concentration (1%) in culture from the beginning of adding Latrunculin A. At the end 
of the experiment, the effect of LatA and FLAG-JN was assessed by staining of 
F-actin using rhodamine-conjugated phalloidin. As expected, F-actin in LatA-treated 
OLN-93 cells became reduced in levels. Overexpression of FLAG-JN obviously 
counteracted the LatA-induced reduction of phalloidin-labeled F-actin, as 
LatA-resistant F-actin-rich clusters in the FLAG-JN-transfected cells mostly 




Figure 3.9 The effect of Juxtanodin in antagonizing F-actin disassembly of 
OLN-93 cells induced by Latrunculin A.  
At 48 hours after transfection of FLAG-JN into OLN-93 cells, 0.25 µM or 0.5 µM of 
Latrunculin A was added into the culture medium of OLN-93 and then the effect was 
monitored by immunofluorescence. LatA-resistant F-actin (red) clusters (arrow) in the 
transfected cells were co-localized with FLAG-JN-positive (green) patches. Scale bars: 
30 μm.  
 
3.2 The effect of Juxtanodin on actin-based cellular structures and behaviors 
3.2.1 Juxtanodin promoted cellular aborization of OLN-93 cells 
OLN-93 cells, a permanent oligodendroglia cell line derived from primary rat brain 
glial cultures (Richter-Landsberg & Heinrich, 1996), showed no JN immunoreactivity 
under normal culture conditions (Zhang et al., 2005; also shown in Fig. 3.10 and Fig. 
3.11A). At low to medium densities, the majority of OLN-93 cells were 
spindle-shaped and bipolar in morphology, although some displayed more than two 
primary cellular processes. In general, the cell bodies and processes were smooth on 
the surface and gave rise to only a few branches. At 48 h after electroporation of 
OLN-93 cells with the flag-tagged JN or GFP, ≈40-80% of cells in the culture 
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expressed the extrinsic protein, as determined by immunocytochemistry. As shown in 
Fig. 3.10, whereas expression of GFP had little effect on the morphology of 
transfected OLN-93 as expected, FLAG-JN-transfected OLN-93 cells exhibited not 
only many primary processes but also finer process arbors with many filopodium-like 
prickles from the processes or directly from the cell bodies in comparison with 
neighboring untransfected cells in the same culture or GFP-transfected OLN-93 cells. 
Some transfected cells also gave rise to lamellopodium-like protrusions (Fig. 3.10).  
 
Figure 3.10 The effect of JN on arborization of OLN-93 cells.  
The effect of JN on cellular arborization was analyzed by immunofluorescence. 
OLN-93 cells expressing exogenous FLAG-JN or GFP were visualized by 
immunofluorescence using anti-JN antibody or anti-GFP antibody (green) and 
neighboring non-transfected control cells were visualized by F-actin staining (red, as 
revealed by binding to rhodamine-conjugated phalloidin). Compared with 
neighboring non-transfected or GFP-transfected control cells, FLAG-JN-transfected 
cells exhibited numerous finer processes with many filopodium-like prickles. Scale 




3.2.2 Juxtanodin promoted cell spreading of OLN-93 cells 
As mentioned above, the majority of OLN-93 cells were spindle-shaped at low to 
medium densities. However, FLAG-JN transfected cells were more spread compared 
with neighboring untransfected cells (Fig. 3.11A) or with the GFP-transfected cells 
(data not shown). Statistical analysis showed significant increases in cellular area of 
FLAG-JN-overexpressing cells (average 323 ± 22% of neighboring untransfected 
cells; n = 28 for JN transfectants and 119 for neighboring untransfected cells; 7 









Figure 3.11 The effect of JN on cell spreading of OLN-93 cells.  
A. The effect of JN on cell spreading was analyzed by immunofluorescence. OLN-93 
cells expressing exogenous FLAG-JN were visualized by immunofluorescence using 
anti-JN antibody (green) and neighboring non-transfected control cells were 
visualized by F-actin staining (red). Compared with neighboring non-transfected 
control cells, FLAG-JN-transfected cells were more spread. Scale bar: 30 μm. B. 
Quantification of the cellular area of FLAG-JN-transfected OLN-93 cells (n = 28) and 
neighboring untransfected cells (n = 119). The cellular area was measured using 
Image J software and the ratio between FLAG-JN-expressing cells and untransfected 
neighboring cells was generated as measure for the relative cellular area of 
FLAG-JN-expressing cells. ***P<0.001, unpaired t test. Values are means±SEM. 
 
3.2.3 Juxtanodin induced the formation of actin fibers of OLN-93 cells and 
localized along the side of actin fibers 




we investigated whether JN can affect cytoskeletal architecture in cells. Because the 
F-actin binding domain of JN was mapped at the last 14 amino acid of the C-terminus 
of JN and GST-JN171 totally abolished the ability of F-acting binding, JN141, a 
deletion mutant lacking the C-terminal 141 amino acids, was expected as the negative 
control in this experiment. OLN-93 cells were therefore transfected with constructs 
directing the expression of the flag epitope-tagged wild type JN or JN141 proteins, 
and their subcellular localization and the F-actin organization of transfected cells were 
analyzed by fluorescence microscopy (Fig. 3.12). Interestingly, the subcellular 
localization and effects on the actin cytoskeleton of FLAG-JN and FLAG-JN141 
proteins were found to be significantly different. OLN93 cells exhibited few 
F-actin-rich protrusions and stress fiber structures at normal culture condition (Zhang 
et al., 2005). In contrast to nontransfected and FLAG-JN141 transfected control cells, 
intense and widespread actin stress fibers were observed in the presence of FLAG-JN. 
These results indicated that ectopical expression of FLAG-JN caused the formation of 
thick actin fibers. The formation of actin stress fibers can result from bundling of 
pre-existing actin filaments or from de novo formation of actin filaments. As 
mentioned above, the content of F-actin stains from FLAG-JN-expressing cells were 
significantly increased compared with that of neighboring cells (i.e. as in Fig. 3.8). 
Thus, the formation of actin stress fibers by FLAG-JN involves de novo formation of 
actin filaments derived from the elevation of actin polymerization or attenuation of 




Moreover, FLAG-JN was mostly localized to the F-actin-accumulated fibers, whereas 
FLAG-JN141 showed a diffuse cytoplasmic pattern in the transfected cells (Fig. 3.12). 
It is consistent with our biochemical study indicating JN directly interacted with 
F-actin in vitro through its C-terminal 14 amino acids F-actin binding domain. 
 
Figure 3.12 Juxtanodin induced the formation of actin fibers of OLN-93 cells and 
localized along the side of actin fibers.  
FLAG-JN-transfected Cells formed thick filamentous structures (arrow) visualized by 
rhodamine-conjugated phalloidin staining (red), which were reminiscent of actin 
stress fibers and associated with FLAG-JN proteins (green) whereas FLAG-JN141 
and F-actin showed a diffuse distribution pattern in JN141-transfected cells. Scale 
bars: 20 μm.  
 
3.2.4 Juxtanodin inhibited cell mobility by its C-terminal F-actin binding domain 
The facts that JN exhibited the ability of stabilizing F-actin raises the possibility that 
Juxtanodin may be involved in OLs migration in physiological condition. To assess 
the effect of overexpression of Juxtanodin on the cells migration, we set up the wound 
healing assay with some modification. Cos1 cell line has been widely used in wound 
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healing assay for examining the possible effect of genes on cellular migration (Chen 
et al., 2004; Huang et al., 2007), and it was also used for such a purpose in the current 
study. The effect of Juxtanodin on cellular migration in oligdodendrocytes and Cos1 
cells were possible to be similar because dynamic assembly and disassembly of actin 
filaments is a major driving force for cell movements (Kim et al., 2011). pXJ40-JN 
and pXJ40-JN141 were individually transfected into Cos1 cells when they were 
grown on ~60% confluence. When cells were grown in a confluent layer, a wound 
was created using a pipette tip. As shown in Fig. 3.13, over a 48-h period, Cos1 cells 
migrated into the scratched area and resulted in "healing" of the wound. FLAG-JN 
transfection suppressed Cos1 cell migration under this condition. Expectably, 
FLAG-JN141, a mutant absent of F-actin binding domain at C-terminus of JN, was 




























Figure 3.13 Juxtanodin inhibited cell migration through its C-terminal F-actin 
domain.  
Pxj40-JN and Pxj40-JN141 were individually transfected into Cos1 cells and wounds 
were marked in the confluent monolayers (Left; scale bar: 200 μm). After incubated 
for 48 hours, the cells were fixed for immuno-fluorescence (Right; Scale bar: 120 μm). 
Arrows indicate transfected cells. By wound healing assay, we demonstrated that 
overexpression of Juxtanodin could inhibit Cos1 migration as compared with the 
neighboring non-transfected cells. JN141 with deletion of the C-terminal domain of 












3.3 The possible regulation of Juxtanodin by phosphorylation and RhoA GTPase 
3.3.1 Phosphorylation of T258 of Juxtanodin did not alter its influence on 
cellular morphology and actin cytoskeleton of OLN-93 cells 
The search of phosphorylation database revealed two conserved phosphorylation sites 
in Juxtanodin. One is at the 258th Threonine (Thr, T) and the other at the 278th Serine 
(Ser, S). Thr258 of JN is conserved in all ERM proteins and its phosphorylation is 
critical for releasing ERM function domains (Ramesh, 2004). To determine the role of 
the possible 258th Threonine phosphorylation sites in Juxtanodin, single point 
mutations of JN were generated using site-directed mutagenesis. The Thr-to-Ala 
(Alanine, A) or Ser-to-Ala mutation prevents phosphorylation, whereas the 
Thr-to-Glu (Glutamine, E) or Ser-to-Glu mutation should mimic phosphorylation 
(Luciano et al., 2004; Anggono et al., 2006). The FLAG-tagged Juxtanodin mutants 
were overexpressed in OLN-93 cells to examine their effects on morphology and actin 
cytoskeleton of transfected cells. However, both FLAG-JNT258A and 
FLAG-JNT258E resulted in no detectable alteration of JN activity upon the 
morphology and actin cytoskeleton of transfected OLN93 cells. Similar to 
FLAG-JN-transfected OLN-93 cells, the FLAG-JNT258A- or 
FLAG-JNT258E-transfectants also exhibited bigger cell sizes, numerous fine 
processes with many filopodium-like prickles and the actin fibers in comparison to 
neighboring untransfected cells or to cells transfected with green fluorescent protein 




Figure 3.14 Effect of T258 phosphorylaiton of Juxtanodin on cellular 
morphology and actin cytoskeleton of OLN-93 cells.  
To determine the role of the possible 258th Threonine phosphorylation site in 
Juxtanodin, a series of single point mutation were generated. At 48 hours after 
FLAG-JNT258A and FLAG-JNT258E, the non-phosphorylation mimicker and 
phosphorylation mimicker of Juxtanodin at Threonine 258 respectively, were 
transfected in OLN-93 cells, indirect-immunofluorence study was performed to 
compare their effects on cellular morphology and actin cytoskeleton to that of GFP 
(as a negative control) and JN. OLN93 cells expressing exogenous GFP, FLAG-JN or 
FLAG-JN mutants were visualized by immunofluorescence using anti-GFP antibody 
or anti-JN antibody (green). The actin cytoskeleton of transfected was visualized by 




3.3.2 Phosphorylation of S278 of Juxtanodin abolished its influence on 
morphology of OLN-93 cells 
The other possible phosphorylation site at the 278th Serine (Ser, S) has been reported 
in moesin (Shu et al., 2004), but its functional significance remains unclear. To 
determine the role of the possible 278th Serine phosphorylation sites in Juxtanodin, 
FLAG-JNS278A and FLAG-JNS278E mutants were generated using site-directed 
mutagenesis. The FLAG-tagged Juxtanodin mutants were overexpressed in OLN-93 
cells to examine their effects on the morphology of transfected cells. FLAG-JNS278E, 
the phosphorylation mimicker of Juxtanodin at S278, was obviously deprived of the 
effect of WT FLAG-JN on arborization of OLN-93 cells. And, the OLN-93 cells 
transfected with FLAG-JNS278E also did not show a bigger cellular size than 
neighboring non-transfected or GFP-transfected control cells, suggesting that the 
effect of JN on cell spreading was also abolished by the phosphorylation at the Serine 
278 site (Fig. 3.15). However, FLAG-S278A, the non-phosphorylation mimicker of 
Juxtanodin at the Serine 278 site, resulted no detectable alteration of JN activity upon 








Figure 3.15 Effect of S278 phosphorylaiton of Juxtanodin on morphology of 
OLN-93 cells.  
To determine the role of the possible 278th Serine phosphorylation site in Juxtanodin, 
a series of single point mutation were generated. At 48 hours after FLAG-JNS278A 
and FLAG-JNS278E, the non-phosphorylation mimicker and phosphorylation 
mimicker of Juxtanodin at Serine 278 respectively, were transfected in OLN-93 cells, 
indirect-immunofluorence study was performed to compare their effects on cellular 
morphology to that of GFP (as a negative control) and FLAG-JN. OLN93 cells 
expressing exogenous GFP, FLAG-JN or FLAG-JN mutants were visualized by 
immunofluorescence using anti-GFP antibody or anti-JN antibody (green). The 
neighboring non-transfected control cells were visualized by F-actin staining (red). 




3.3.3 Phosphorylation of S278 of Juxtanodin abolished its influence on cellular 
actin cytoskeleton of OLN-93 cells 
JN phosphorylation at Ser278 modulated actin dynamics in vitro. However, in cells 
the precise consequences of JN phosphorylation at for Ser278 the F-/G-actin ratio and 
cytoskeleton dynamics have remained obscure. We next analyzed the potential of 
FLAG-JN Ser278 mutants to induce actin cytoskeletal changes. Actin structures of 
OLN-93 cells were visualized by staining of rhodamine-conjugated phalloidin. 
Consistent with the findings from Fig. 3.12, ectopical expression of wild-type 
FLAG-JN obvious enhanced the formation of actin stress fibers (Fig. 3.16), which 
thickened and increased in number over those found in the GFP-expressed cells. In 
contrast, ectopical expression of the FLAG-JNS278E mutant did not induce obvious 
actin fiber formation in all transfected-cells, suggesting that phosphorylation at serine 
278 abolished the ability of JN to induce the dramatic formation of actin stress fibers 
in transfected cells. Additionally, we also used immunofluorescence to visualize the 
subcellular location of JN phosphorylation mutants in the transfected OLN-93 cells. 
Contrast with the localization of FLAG-JN with induced stress fibers characterized 
with prominent F-actin staining, FLAG-JNS278E showed a diffuse location pattern. 
However, FLAG-S278A, the non-phosphorylation mimicker of Juxtanodin at the 
Serine 278 site, resulted in no detectable alteration of JN activity upon the cellular 
actin cytoskeleton of transfected OLN93 cells (Fig. 3.16).  
 
These findings are consistent of the loss of inhibition on F-actin disassembly in vitro 
and induction of arborizaiton of transfected cells for JNS278E and strongly suggest 
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that specific phosphorylation at the site of Serine 278 negatively interfered with JN 
activity in cells. 
 
 
Figure 3.16 Effect of S278 phosphorylaiton of Juxtanodin on cellular actin 
cytoskeleton of OLN-93 cells.  
To determine the role of the possible 278th Serine phosphorylation site in Juxtanodin, 
a series of single point mutation were generated. At 48 hours after FLAG-JNS278A 
and FLAG-JNS278E, the non-phosphorylation mimicker and phosphorylation 
mimicker of Juxtanodin at Serine 278 respectively, were transfected in OLN-93 cells, 
indirect-immunofluorence study was performed to compare their effects on cellular 
actin cytoskeleton to that of FLAG-JN. OLN93 cells expressing exogenous FLAG-JN 
or FLAG-JN mutants were visualized by immunofluorescence using anti-JN antibody 
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(green). The actin cytoskeleton of transfected cells was visualized by 
rhodamine-conjugated phalloidin staining (red). Scale bars: 20 μm. 
 
3.3.4 Inhibition of RhoA magnified the arborization of CHO cells induced by 
Juxtanodin 
The Rho GTPases, including RhoA, Rac and Cdc42, are known for their regulation of 
the actin cytoskeleton (Ridley et al, 2006). Previous in vitro studies have shown that 
maturation of oligodendrocyte is accompanied by inhibition of RhoA (Liang et al, 
2004). Here, the possible roles of RhoA GTPase in regulation of Juxtanodin were 
investigated. 
 
To study the possible regulation of RhoA GTPase on JN activity, we specifically 
blocked or increased their activity by transiently transfecting CHO cells with 
dominant negative or dominant positive mutants of RhoA GTPase. CHO cells were 
applied here because the RhoA GTPase has been well studied in CHO cells (Krall et 
al., 2002; Karpushev et al., 2010). RhoA activation induces the assembly of 
contractile actin-myosin filaments (stress fibers) in CHO cells (Etienne-Manneville 
and Hall, 2002). We used expression plasmid with the dominant positive mutant of 
RhoA (pxjRhoV14), which mimics the constitutively GTP-bound state, or the 
dominant negative mutant of RhoA (pxjRhoN19), which mimics the GDP-bound state 
for transient transfection of CHO cells (Raman et al., 1999).  
 
As shown in Fig. 3.17, co-transfection of constitutively dominant negative RhoA 
(Rho-) with JN in CHO cells induced more complicated arborization than 
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co-transfection of constitutively dominant active RhoA (Rho+) with JN (Fig. 3.17). 
 
 
            
Figure 3.17 Inhibition of RhoA magnified the arborization of CHO cells induced 
by Juxtanodin.  
CHO cells were transfected JN with either dominant-negative (RhoA-) or 
constitutively active (RhoA+) Rho and processed for indirect immunofluorescence 
microscopy. After 48 h, cells were fixed and stained against flag-epitope and JN to 
visualize the ectopically expressed RhoA mutant proteins and Juxtanodin, 
respectively. 488 anti-mouse staining showed the transfected flag-tagged RhoA 
(green), whereas 568-conjugated anti-rabbit secondary antibody indicated the 



































4.1 Binding of Juxtanodin with F-actin 
The previous immunoprecipitation study in our lab showed that Juxtanodin interacted 
with actin in vivo. Later, GST-pulldown assay to identify the potential interaction 
partners of Juxtanodin in our lab further confirmed this interaction of Juxtanodin with 
actin in vivo. In the current study, the in vitro actin co-sediment assay demonstrated 
that this interaction was directly between F-actin and JN but not mediated by other 
proteins. By deletion of different domains of Juxtanodin, we also demonstrated that its 
C-terminal 14 amino acid residues were indispensable for the interaction of JN with 
F-actin, as JN268 which lacked the last 14 amino acid was almost devoid of binding 
ability with F-actin. These amino acid residues were part of the putative F-actin 
binding domain at C-terminus of Juxtanodin, which was firstly identified and mapped 
to the C-terminal 34 amino acid in ezrin, radixin and moesin (Turunen et al., 1994).  
 
Quite interestingly, Juxtanodin exhibited the stronger binding activity to F-β-actin 
than to F-α-actin. Although actin is a highly conserved protein and the difference of 
amino acid sequence between cytoplasmic β-actin and skeletal α-actin is less than 
10% (Chang et al., 1984), they display several structural differences, including the 
N-terminus of skeletal α-actin bearing a helical rather than the turn structure in β-actin, 
the obvious difference in rotation within the subdomains of actin isoforms (Schutt et 
al., 1993). The functional differences such as the interaction of actin binding proteins 
with actin isoforms are also reported. For instance, profilin exhibits stronger affinity 
to cytoplasmic β-actin than sarcomeric actin (Rozycki et al., 1991). For ERM proteins, 
Discussion 
 103
the ability of their F-actin binding domain to discriminate between actin isoforms is 
still controversial. The interaction of ezrin with actin showed isoform preference, 
because it localized with β-actin in parietal cells, and purified parietal cell ezrin bound 
β-actin with a higher affinity than muscle α-actin, and selectively promoted assembly 
of β-actin (Yao et al., 1995, 1996). However, moesin isolated from activated platelets, 
or ezrin activated in vitro by protein kinase C-θ (PKC-θ), did not show any difference 
in binding with actin isoforms (Nakamura et al., 1999; Simons et al., 1998). In the 
present study, Juxtanodin was in vitro expressed in E.coli and then purified by FPLC. 
The high purity enabled us to investigate the isoform preference of this F-actin 
binding domain without contamination with lipid or other proteins.  
 
4.2 Effect of Juxtanodin on actin dynamics 
The ability of Juxtanodin to induce cellular process extension and ramification is 
reminiscent of that of the C-domain of ERM proteins (Martin et al., 1997; Litman et 
al., 2000). The effect of Juxtanodin and ERM on cellular arborization seems 
dependent on their ability of F-actin binding, because: 1) deletion of its C-terminal 14 
amino acid F-actin binding site abolished its influence on cellular arborization (Zhang 
et al., 2005); 2) co-expression of an N-terminal fragment (residues 1–115) of ezrin, 
which could mask the F-actin binding site of C-terminal domain of ERM proteins, 
antagonized its effect on process extension in some circumstances (Martin et al., 
1997). These results suggested that the F-actin binding domains of Juxtanodin and 
ERM family have similar effect on actin dynamics and is indispensable to generate 
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process extension by JN and ERM proteins.  
 
Previous study showed that purified parietal cell ezrin could regulate actin dynamics 
by promoting assembly of β-actin (Yao et al., 1996). However, as revealed by the 
present results, JN had no influence on actin polymerization. Although additional F- 
and G-actin-binding sites at 280-309 were identified in ezrin (Roy et al., 1997), which 
partly explained the ability of ezrin to promote actin assembly by providing 
nucleation sites, these sites were not detected by blot overlay assaying GST fusions or 
untagged N- and C-terminal domains of moesin, radixin and merlin (Huang et al., 
1999). As demonstrated by our study, JN also did not exhibit other F- or G-actin 
binding sites except for the C-terminal F-actin binding domain. Therefore, JN and 
ERM proteins regulate actin dynamics by still some other characters of the C-terminal 
F-actin binding domain.  
 
Furthermore, Juxtanodin was found to inhibit the disassembly of F-β-actin at both 
biochemical and cellular levels. Some F-actin binding proteins stabilize actin 
cytoskeleton by bundling pre-existing actin filaments, such as Fascin and α-actinin 
(Hashimoto et al., 2007; Coghill et al., 2003). However, as mentioned above, 
Juxtanodin has no activity of bundling F-actin. An F-actin bundling protein usually 
presents at least two F-actin binding sites or exhibits the ability of forming dimmer for 
its bundling activity. As revealed in this study, Juxtanodin had only one F-actin 
binding site at its C-terminus. The result of discontinuous native PAGE in our lab also 
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showed FLAG-tagged JN existed mostly as monomers when overexpressed in 
cultured OLN-93 cells. These results are in line with JN lacking F-actin-bundling 
activity. Instead, JN was found to concentrate along F-actin-rich fibers of transfected 
cells, implying binding of JN to the side of actin filaments in vivo, which presents a 
reasonable explanation for its inhibitory effect on F-actin depolymerization. 
Thomomin is firstly described to prevent actin filament disassembly by the lateral 
binding to the actin filament (Broschat et al., 1990). Recently, merlin has also been 
shown to inhibit F-actin disassembly through a lateral association (James et al., 2001). 
In addition, the current study demonstrated no activity of JN to binds G-actin, nor to 
alter the rate of actin nucleation/elongation during polymerization. These observations 
indicate the inhibitory effect of JN on F-actin depolymerization is not due to capping 
of the ends of actin filaments or to nucleating activity. Recently, Peles group reported 
that endogenous Ermin, the ortholog of Juxtanodin in mouse, was accumulated in 
spikes at the tip of F-actin-rich processes (termed "Ermin spikes") in cultured primary 
oligodendrocytes (Brockschnieder et al., 2006). The concentrate of Juxtanodin at 
F-actin-rich spikes supports the option that Juxtanodin could directly bind and 
stabilize F-actin in vivo. This is also in agreement with the present observation that JN 
countered the F-actin depolymerizing effect of LatA in cultured OLN-93 cells.  
 
4.3 The possible roles of JN in oligodendrocyte differentiation, migration, 
myelination and specialization of the node of Ranvier 
In the nervous system, neurons and glia have a functional relationship, which is most 
evidenced by the process of myelination. During development oligodendrocytes 
Discussion 
 106
undergo proliferation, migration and differentiation. Once oligodendrocytes encircle 
the bundles of neuron axons, each oligodendrocyte cell then selects axons from nerve 
bundles and initiates the process of myelination (McTigue and Tripathi, 2010). 
Recently, the role of actin-binding proteins has been studied extensively during 
oligodendrocyte development and myelination (Hill and Harauz, 2005; Sloane and 
Vartanian, 2007; Kippert et al., 2009; McTigue et al., 2008). Actin-binding proteins 
influence multiple developmental processes of oligodendrocyte cells such as 
proliferation, migration, differentiation and myelin extension (Sloane and Vartanian, 
2007; Schulz et al., 2009; Bacon et al., 2007). 
 
The maturation of oligodendrocytes is characterized by process outgrowth and 
refinement (Piaton et al., 2010). Protrusions of oligodendrocytes function in initiation 
of myelination (Nave et al., 2010), sensing the cell environment (Murakami et al., 
1989), and making dynamic adhesions to extracellular matrix and axons (Dennis et al., 
2008). In consistent with the previous study (Zhang et al., 2005), we found that JN 
transfection promoted process arborization of cultured OLN-93, suggesting that JN 
plays a critical role in oligodendrocyte differentiation. The effect of JN on cellular 
arborization should be achieved by its actin cytoskeleton-stabilizing activity because 
the deletion of the C-terminal F-actin binding domain abolished JN’s ability to induce 
cell arborization. In deed, other actin cytoskeleton-stabilizing proteins such as merlin 




Before oligodendrocyte maturation, oligodendrocyte progenitors undergo extensive 
migration, as demonstrated by transplantation and lineage tracing in the central 
nervous system (Levison and Goldman, 1993; Warrington et al., 1993). These cells 
originate within subventricular zones (Small et al., 1987). On reaching their final 
destinations oligodendrocyte progenitors differentiate, ensheath and myelinate single 
axons (Buckley et al., 2010). Migration of the oligodendrocyte is highly regulated 
(Barres et al., 1992; Barres and Raff, 1994) and it seems that actin-binding proteins 
spatiotemporally control the migration process. It has recently been suggested that the 
high concentration of the actin-binding protein gelsolin in the oligodendrocyte lineage 
is responsible for the considerable motile ability of O-2A progenitors (Tanaka and 
Sobue, 1994; Lena et al., 1994). Indeed, in fibroblasts, gelsolin usually localizes to 
cytoplasm undergoing rapid protrusive activity (Cooper et al., 1988) and its 
overexpression in transfected NIH 3T3 fibroblasts produces enhanced motility 
(Cunningham et al., 1991; Laine et al., 1998). The deficiency of some actin-binding 
proteins in a functional way has also been shown to affect the migration of 
oligodendrocytes. For example, platelet-derived growth factor (PDGF) stimulated the 
oligodendrocyte migration through phosphorylation of WAVE2, a protein promoting 
actin polymerization through its ability to active Arp2/3 complex, at the site of serine 
137 by cyclin-dependent kinase 5 (Miyamoto et al., 2008). Functional inhibition of 
WAVE2 achieved by infection of the WAVE2 construct harboring the Ser-137-to-Ala 
significantly reduced PDGF-dependent migration of oligodendrocytes in vitro 
(Miyamoto et al., 2008). Moreover, within growth cone-like leading edges of 
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migratory oligodendrocyte processes, F-actin was found to be colocalized with 
myosin (Simpson et al., 1999). Inhibition of the myosin ATPase by BDM, which 
prevents actin-myosin interactions, greatly inhibited the oligodendrocyte migration at 
concentrations that did not disrupt cell morphology (Simpson et al., 1999). Whereas 
enrichment of gelsolin in oligodendrocytes may cause rapid remodelling of the actin 
cytoskeleton and active migration (Tanaka et al., 1994; Stewart et al., 1988), the 
development of high-order actin fibers is necessary for inhibition of cell migration. In 
the current study, we find that JN could inhibit cellular migration by would healing 
assay, which seemed to rely on its actin cytoskeleton-stabilizing activity because 
JN141 mutant was devoid of this property. Cellular motility is powered by actin 
filament assembly and disassembly (Pollard, 2002). In other words, actin disassembly 
at the pointed end is critical for F-actin turnover (also called Treadmilling), which 
provides the force essential for cell motility (Pollard and Borisy, 2003; Pantaloni et al., 
2001). JN could prevent F-actin disassembly; therefore it is not surprising that JN 
inhibited cellular migration through suppressing F-actin turnover. Indeed, the 
inhibitory activity of JN on cell migration coincides with its late stage expression in 
brain (Zhang et al., 2005) because oligodendrocytes migrate to and stop near neuronal 
axon at their late stage of a complex and precisely regulated timed program of 
proliferation, differentiation and migration finally to form the myelin (Kirby et al., 
2006).  
 
Notably particularly, in the current study we found that JN actually inhibited cell 
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migration although it could induce filopodia in the cultured cells. Generally, it is 
thought that filopodia are associated with active cellular migration (Machesky, 2008). 
Because filopodia function as antennae for cells to probe their environment, filopodia 
have been thought to play an important role in cell migration (Mattila and 
Lappalainen, 2008). However, the coincidence of filopodia formation and reduced cell 
motility has been reported. For instance, a recent study (Dayma et al., 2011) found 
that overexpression of C3G, an exchange factor for Ras family of small GTPases, 
induced neurite-like extensions which were actin-rich in cultured carcinoma cells. 
Meanwhile, time lapse analysis showed reduced motility of C3G expressing cells, 
which was due to defects in formation of substratum adhesions in the transfected cells. 
Interestingly, the coincidence of filopodia formation and reduced cell motility in 
JN-expressed OLN-93 cells seems to match the physiological program of 
oligodendrocytes in vivo because oligodendrocytes start to establish its aborized 
morphology on stopping near the neuronal axon (Buckley et al., 2010). 
 
The shiverer mutant mouse is an autosomal recessive mutant characterized by 
incomplete myelin sheath formation in CNS. Such mice contain a deletion in the MBP 
gene, do not produce MBP proteins, and have little or no compact myelin in the CNS 
(Seiwa et al., 2002). Further studies showed that MBP can polymerize actin, bundle 
F-actin filaments, and bind actin filaments to lipid bilayers through electrostatic 
interactions (Boggs et al., 2000 and Boggs et al., 2006). Moreover, MBP could be 
posttranslationally modified by six arginines deiminated to the uncharged residue 
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citrulline and this modification has been found to increase in multiple sclerosis, a 
popular disease caused by damage of myelin sheath (Boggs et al., 2005). Biochemical 
studies showed that this posttranslational modification of MBP actually attenuated the 
ability of MBP to polymerize and actin bundles (Boggs et al., 2005). Taken together, 
these results suggested that the formation of F-actin/actin bundles is critical for 
maintenance of myelin sheath in vivo. In current study, JN was found to stabilize 
F-actin in vitro and in vivo and it also could induce actin fiber formation in the 
cultured cells, therefore it is not surprising that JN possibly participates in myelin 
sheath maintenance in vivo like MBP.  
 
Previous studies including confocal microcopy and immunoelectron microscopy 
revealed that JN also existed in lateral terminal loops neighboring the node of Ranvier 
(Zhang et al., 2005). The conventional terminal (paranodal) loops of myelin sheath 
are not homogeneous in their molecular composition (Bhat, 2003). The JN-positive 
lateral terminal loops neighboring the node of Ranvier clearly differ from those 
JN-negative medial terminal loops adjoining the juxtaparanode. Accompanying this 
molecular heterogeneity, functional disparity between the two regions is expected. 
The former might, for example, be more related to myelin-axon interaction or to 
induction/sustaining of the node of Ranvier, whereas the latter may be more involved 
in the formation/maintenance of compact myelin lamellae. In the peripheral nervous 
system, ERM proteins enriched in the perinodal Schwann cell microvilli are strongly 
implicated in inducing Ranvier node formation (Scherer et al., 2001; 
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Melendez-Vasquez et al., 2001; Gatto et al., 2003). In the CNS, oligodendrocytes are 
known to similarly direct nodal Na+ channel clustering but are devoid of ERM 
proteins. In fact, the actin cytoskeleton can regulate ion channel distribution; Levina 
et al. (1994) have demonstrated that local disruption of the cortical cytoskeleton in the 
growing tip of the oomycete alters the distribution of ion channels in the cell, 
provoking an intracellular signal cascade. Considering the similar molecular 
structures and activities of Juxtanodin and ERM proteins, it is possible that JN 
regulates ion channel distribution in CNS similar to the ERM proteins in PNS through 
its actin cytoskeleton-stabilizing activity.  
 
4.4 Significance of regulation of Juxtanodin by phosphorylation and RhoA 
GTPase 
Functions of ERM proteins are conformationally regulated, that is, the full-length 
dormant molecule has its activities masked because the N-terminal domain binds very 
tightly to its C-terminal domain (Ramesh, 2004). Activation of ERM proteins is 
predicted to require the separation of the N- and C-terminal domains, thereby 
exposing the C-terminal F-actin binding site and potential membrane association sites 
in the N-terminal domain of ERM (Ramesh, 2004). Phosphorylation of a conserved 
threonine residue in ERM proteins (Thr558 in moesin) results in activation of these 
proteins by disrupting the intramolecular and intermolecular self-associations. 
Although JN lacks the N-terminal FERM domain which is conserved in ERM proteins, 
it shares the almost identical C-terminus with ERM proteins and retains the conserved 
threonine site (T258). To our surprise, however, clear influence of T258 modifications 
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in JN was not found on host cell morphology and actin organization. This is possibly 
because 1) JN lacks the N-terminal FERM domain of ERMs for intramolecular or 
intermolecular self-association/masking, and 2) there might not be a FERM 
domain-containing protein in OLN-93 or even in OLs that interacts with and masks 
JN C-terminal actin-binding domain in a JNT258 phosphorylation-dependent way. 
 
In contrast, phosphorylation modification of Serine 278 of JN produced surprising 
alterations in JN molecular and cell biological activities. The corresponding Serine 
residue in mouse moesin, S565, was identified in a proteome-wide analysis of murine 
WEHI-231 B lymphoma cells and the authors suggested that the phosphorylation site 
might be involved in B-cell signaling pathway (Shu et al., 2004). In the present study, 
we found that the phosphorylation of this serine residue obviously abolished JN 
effects on F-actin depolymerization and on host cell arborization/actin fiber 
organization. The mechanism of this S278 phosphorylation-dependent regulation of 
JN activity remains elusive. The functional importance of this 
phosphorylation-dependent regulation of JN activity, however, is unambiguous. It not 
only provided the possibility for regulating the activity of this regulatory protein for 
actin cytoskeleton, but also integrated the action of JN into the complex signaling 
pathways and functional context of the host cell.  
 
Indeed, modification of phosphorylation is an important and general way for 
regulation of actin binding proteins, such as calcium/calmodulin-dependent protein 
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kinase IIβ (CaMKIIβ) (Lin, et al., 2008), heLIM and SH3 domain protein (LASP) and 
Cortactin (Webb et al., 2006). Their binding to F-actin, important for the in vivo 
maintenance of polymerized F-actin, was disrupted when highly phosphorylated. In 
OLs, the important actin binding proteins, like MBP and myosin II, are also regulated 
by phosphorylation for actin interaction. The results from Boggs et al (2006) showed 
that phosphorylation at two sites of MBP with mitogen-activated protein kinase 
(MAPK) could attenuate the ability of MBP to polymerize and bundle actin. Both 
oligodendrocytes and myelin contain several kinases that can phosphorylate MBP on 
Ser and Thr and phosphatases that can mediate rapid turnover of phosphate groups 
(Lamprianou et al., 2006; Fraser et al., 2008; Kuo et al., 2010). Turnover is highest in 
the most mature myelin. Expectedly, the mechanism for the phosphorylation turnover 
of Juxtanodin is present in myelin to regulate the interaction of JN with actin. In fact, 
JN has been shown not to always colocalize with actin filaments in brain of adult rat 
(Unpublished data and Tang et al., 2009). The dissociation of JN and actin filaments 
in vivo possibly involves the phosphorylation of Serine 278 of JN.  
 
Rho GTPases recycle between the GTP-bound (active) and GDP-bound (inactive) 
states (Heasman and Ridley, 2008). They respond to different extracellular signals for 
guiding various cellular behaviors. This ability is achieved by the interaction of Rho 
GTPases with many effectors in cells and it is precisely regulated (Koh, 2006). Recent 
work has revealed that Rho GTPases such as RhoA play critical roles in myelination 
at PNS and CNS (Thurnherr et al., 2006; Kippert et al., 2007; Paintlia et al., 2008; 
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Feltri et al., 2008). Although Rho GTPases play important roles in oligodendrocytes 
development, they are not the ideal targets for therapeutic approaches because of their 
ubiquitous distribution in different tissues. To avoid altering numerous cellular 
processes, it is intriguing to explore the intrinsic specificity of Rho GTPases to 
display distinct functions. In the case of myelination by oligodendrocyte at CNS, it is 
valuable to identify the specific regulating factors or effectors for the Rho GTPases, 
therefore providing possible specific targets for potential myelin-deficient therapeutic 
approaches without altering numerous cellular processes. For example, myelin has 
been found to inhibit oligodendrocyte differentiation in some demyelination diseases 
(Rosenberg et al., 2006). The inhibitory effects of myelin on remyelination are 
partially mediated by Fyn-RhoA-ROCK signaling pathway. The siRNA or 
pharmacological-mediated inhibition of RhoA-ROCK is able to restore 
oligodendrocyte differentiation in the presence of myelin. Identifying the specific 
downstream effectors of RhoA-ROCK signaling pathway in oligodendrocyte will 
provide a mechanism which could be of significant therapeutic value (Baer et al., 
2009).  
 
In the current study, we found that inhibition of RhoA could amplify the activity of 
JN on cellular arborization. This result seems consistent with the well-documented 
conclusion that RhoA and its major downstream effectors ROCK are inactivated 
during myelination at PNS and CNS (Bandtlow, 2003; Yamauchi et al., 2004; Mi et 
al., 2004). In the PNS, the expression of RhoA and two isoforms of ROCK, ROCK1 
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and ROCK2, is dropping afterward myelination (Melendez-Vasquez et al., 2004). 
Moreover, integrin-linked kinase (ILK), a β1-integrin binding partner (Hannigan et al., 
1996), is demonstrated to negatively regulate Rho/ROCK signaling, thereby 
promoting Schwann cells process extension during radial sorting of axon bundles. 
Inhibition of ROCK by its inhibitor, either Y27632 or fasudil, restores process 
extension of ILK-mutant Schwann cells in culture. The negative regulation of 
Rho/ROCK by ILK could be reached by different mechanisms, including 
integrins-Fyn kinase pathway. The activation of Fyn kinase leads to the 
phosphorylation of p190Rho, a GTPase-activating protein (Schober et al., 2007), 
which promotes RhoA inactivation. In the oligodendrocytes of CNS, the similar role 
of Rho/ROCK has been indentified. Oligodendrocytes cultured on the 
fibronectin-coated slides exhibit pronounced process outgrowth, which is mediated 
through an integrins-Fyn kinase pathway (Liang et al., 2004). Fyn kinase inhibits the 
activity of RhoA through p190RhoGAP. Moreover, expression of constitutively active 
RhoA has been demonstrated to prevent oligodendrocyte process extension (Wolf et 
al., 2001; Liang et al., 2004). Although our results are still not sufficient to indentify 
JN as the downstream effector of Rho/ROCK, it is intriguing and worth for further 
studies especially considering that the possible phosphorylation of JN (JNS278E) 
abolished the activity of JN on cell arborization.  
 
4.5 Conclusions 
In this study, it was found that JN could interact with actin and this interaction was 
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directly mediated by its C-terminal F-actin binding domain, which comprised the last 
14 amino acid of JN. The studies on the role of JN in actin dynamics showed that it 
could prevent F-actin depolymerization in vivo and in vitro, suggesting that JN may 
stabilize F-actin based structure and behaviors in oligodendrocyte. As expected, JN 
over-expression in the cultured oligodendrocyte cell line dramatically induced the 
formation of F-actin-based cellular structures, such as filopodia at the cell edge and 
stress-fiber in the cytoplasm. JN also promoted cell spreading and inhibited cellular 
migration.  
 
As expected, the effect of Juxtanodin on actin cytoskeleton stability should be 
precisely regulated and reversible in vivo, which is supported by the fact that JN 
partially co-localized with F-actin in oligodendrocyte in central nervous system. In the 
current study, the phosphorylation at its 278th serine residue has been demonstrated to 
abolish the JN effect on actin dynamics and actin-based structures/behaviors at the 
biochemical and the cellular levels. Further study implied that RhoA GTPase is 
possibly involved in the phosphorylation of serine 278 of JN. 
 
Taken together, our results point to Juxtanodin as an actin cytoskeleton-stabilizing 
protein that plays active roles in migration, differentiation of oligodendrocytes and 
maintenance of the myelin sheath. The results also suggest phosphorylation 




4.6 Future studies 
In current study, we found that Juxtanodin could stabilize actin cytoskeleton of 
cultured oligodendrocyte cell line, which provided the molecular mechanism for the 
effect of JN on oligodendrocyte behaviors such as migration and differentiation. It 
would be worthy to verify these points in the primary cultures of oligodendrocytes. 
Furthermore, the exact role of Juxtanodin in oligodendrocyte development, the 
formation of myelin and node of Ranvier in vivo is still elusive. It is quite worthy to 
generate the Juxtanodin-knockout mice to investigate these issues. In our lab, we have 
not detected JN’s expression in primary oligodendrocytes extracted from adult rat 
brain (Zhang et al., 2005). Successful establishment of JN-expressed primary 
oligodendrocytes or cell lines would benefit much to JN-function studies using 
reverse methods, such as siRNA against JN. Also, it could be considered to establish 
oligodendrocyte and neuron co-culture to simulate the formation of myelin and node 
of Ranvier in vitro. In this co-culture model, the role of Juxtanodin in the formation of 
myelin and node of Ranvier could be investigated by knockdown or overexpression 
methods. 
 
In this study, we also found that Juxtanodin contained a possible phosphorylation site 
at the 278th serine residue and this site significantly regulated the activity of 
Juxtanodin on F-actin binding and stabilization. Although the studies in our lab have 
showed that Juxtanodin is phosphorylated in vivo and in culture OLN-93 cells, we still 
could not confirm that the phosphorylation site of Juxtanodin just exists at the 278th 
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serine residue. Therefore, it is worthy to generate the antibody against the 
phosphorylated-serine at 278th residue to check the phosphorylation status of 
Juxtanodin in vivo. It is also interesting to observe the change of JN-expressed 
OLN-93 cells in morphology/behaviors after treated with okadaic acid, a serine 
phosphatase inhibitor. Furthermore, it is intriguing to identify the kinase responsible 
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